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SUMMARY
Background: Cardiac hypertrophy is an adaptive process occurring in response to
mechanical overload or tissue injury. The stimuli for cardiac hypertrophy are diverse
and vary from increased afterload on the heart to cardiac remodeling in response to
cytokines. Amongst others, obesity is characterized by excessive body weight
resulting in metabolic disorders. This excess body weight necessitates an increased
blood and oxygen delivery to the peripheral tissues, which is achieved by an elevated
cardiac output. Total blood volume is also increased in the obese due to the
increased tissue volume and vascularity. With time, the obesity induced increase in
cardiac preload results in left ventricular hypertrophy and dilatation. Obesity is also
associated with complications such as hypertension, insulin resistance and impaired
glucose metabolism.
In addition, adipose tissue has been implicated to contribute to elevated circulating
TNFa levels in obesity and may contribute to the pathophysiology of the heart in
obese individuals. The heart is a major cytokine-producing organ that generates
amongst others tumor necrosis factor a (TNFa). TNFa is a proinflammatory cytokine,
which acts to increase its own production, has cytotoxic and cytostatic effects on
certain tumor cells and influences growth and differentiation in virtually all cell types
including cardiomyocytes. Elevated levels of TNFa are detected peripherally in
almost all forms of cardiac injury and in hypertrophic cardiomyopathy. These
elevations are proposed to be deleterious to the heart, although an adaptive role for
low levels of TNFa has been proposed.
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Aim: The aim of the study was to determine whether there is a correlation between
obesity and serum, myocardial, and adipose tissue TNFa levels and cardiac
hypertrophy. We also wished to determine whether the hearts from the obese
animals functioned normally under normoxic conditions and whether they responded
differently to ischaemia/reperfusion when compared with their concurrent controls.
Materials and Methods: Male Sprague-Dawley rats (n=100) were fed a high caloric
diet (HCD) containing 33% rat chow, 33% condensed milk, 7% sucrose and 27%
water, or standard laboratory rat chow for 6-12 weeks. Food consumption, body
weight gain, heart weight and tibia length were measured. Serum glucose, insulin
and lipid levels were also determined. Hearts were excised and perfused on the
isolated Working Heart perfusion apparatus and cardiac function was monitored and
documented. Hearts were then subjected to 15 minutes of total global ischaemia at
370C, and reperfused for 30 minutes. Cardiac function was again documented.
A separate series of hearts were freeze-clamped at different time points during the
experimental protocol and stored in liquid nitrogen for the determination of myocardial
TNFa and cGMP levels. Serum TNFa levels were determined after 12 weeks on the
high caloric or normal/control diet. After 12 weeks on the diet myocardial TNFa levels
of the HCD fed animals and their concurrent controls were determined before and
during ischaemia. Adipose tissue and myocardial tissue TNFa levels were also
determined after 6, 9 and 12 weeks on the respective diets. Myocardial cGMP levels
were measured in the HCD fed rats and the control rats after 6, 9, and 12 weeks.
These data were used as an indirect index to determine whether the myocardial NO-
cGMP pathway was activated in the normoxic hearts on the respective diets.
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Results: The body weight of the HCO fed animals was significantly higher compared
with their respective controls after 12 weeks on the diet (459.9 ± 173.8 g and 271.5 ±
102.6 g respectively (p<0.05». The HCO fed animals also had heart weight to body
weight ratios that were significantly greater compared with the controls (4.2 ± 0.1
mglg and 3.7 ± 0.1 mglg respectively (p<0.05».
The plasma glucose levels of the HCO fed animals were higher than their respective
controls (9.2 ± 0.3 mmoiII and 7.8 ± 0.3 mmoiII respectively (p<0.05)), but their insulin
levels were similar (12.87 ± 1.02 IlIUlml and 12.42 ± 5.06 IlIU/ml). Plasma lipid
profiles (plasma cholesterol, high density lipoprotein (HOL) cholesterol and plasma
triacylglyceride (TAG)) were abnormal in the HCO fed animals compared with the
control rats. Plasma TAG levels in the HCO fed animals were significantly higher
compared with the control rats (0.664 ± 0.062 mmoiII and 0.503 ± 0.043 (p<0.05»,
while plasma cholesterol levels (1.794 ± 0.058 mmoIII and 2.082 ± 0.062 mmoiII
(p<0.05» and HOL cholesterol levels were significantly lower (1.207 ± 0.031 mmoiII
and 1.451 ± 0.050 mmoiII (p<0.05».
Cardiac mechanical function was similar for both groups before ischaemia, but the
percentage aortic output recovery was lower for the hearts from the HCO fed animals
when compared with their controls (47.86 ± 7.87% and 66.67 ± 3.76 % respectively
(p<0.05».
Serum TNFa levels of the HCO fed animals were higher compared with the control
animals (51.04 ± 5.14 AU and 31.46 ± 3.72 AU respectively (p<0.05», but myocardial
TNFa levels remained lower in these animals (312.0 ± 44.7 pglgram ww and 571.4 ±
v
Stellenbosch University http://scholar.sun.ac.za
132.9 pg/gram ww respectively (p<0.05)). During ischaemia these myocardial TNFa
levels increased above those of the controls (442.9 ± 12.4 pg/gram ww and 410.0 ±
12.5 pg/gram ww respectively (p<0.05)). The adipose tissue TNFa levels were
significantly increased after 12 weeks on the high caloric diet compared with the
control animals (4.4 ± 0.4 pg/gram ww and 2.5 ± 0.3 pg/gram ww respectively
(p<0.05)). There was no significant difference in the myocardial cGMP levels of the
HCD rats compared with the conrol rats after 6, 9 and 12 weeks.
Conclusion: 1) The high caloric diet induced obesity, which lead to cardiac
hypertrophy in this study. 2) There was a strong correlation between elevated
adipose tissue and serum TNFa levels, and cardiac hypertrophy. 3) Elevated serum
TNFa levels did not lead to activation of the myocardial NO-cGMP pathway in the
normoxic hearts in this model. 4) The hypertrophied hearts from the HCD fed animals
had poorer post-ischaemie myocardial functions than their concurrent controls.
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OPSOMMING
Agtergrond: Miokardiale hipertrofie is In aanpassing wat gebeur as In gevolg van
meganiese oorbelading of weefsel beskadiging. Verskillende stimuli kan tot
miokardiale hipertrofie aanleiding gee soos byvoorbeeld In verhoging in nalading, of
miokardiale hermodellering in respons op sitokiene. Verhoging van voorbelading in
vetsug mag ook tot hipertrofie aanleiding gee. Vetsug word gekenmerk deur In
oormatige liggaamsmassa wat tot metaboliese versteurings lei. Die oormatige
liggaamsmassa vereis In verhoging in bloed- en suurstofverskaffing aan die perifere
weefsel wat deur In verhoging in die kardiale uitset vermag kan word. Die bloed
volume van In vetsugtige individu word ook verhoog as gevolg van In verhoging in
weefselvolume en vaskulariteit en met verloop van tyd induseer die verhoogde
kardiale voorbelading linker ventrikulêre hipertrofie en dilatasie. Vetsug word ook met
verskeie ander siekte toestande soos hipertensie, insulien weerstandigheid en
versteurde glukose metabolisme, geassosieer.
Vetweefsel dra ook by tot verhoging van tumor nekrose faktor alfa (TNFa) vlakke in
die bloed, wat op sy beurt tot miokardiale hipertrofie mag bydra. TNFa is In pro-
inflammatoriese sitokien wat sy eie produksie kan stimuleer. Dit het ook sitotoksiese
en sitostatiese effekte op sekere tumor selle en kan groei en differensiasie in bykans
alle seltipes, insluitende kardiomiosiete, stimuleer. Die hart kan ook TNFa produseer
en verhoogde TNFa vlakke word feitlik in alle vorms van miokardiale besering en
hipertrofiese kardiomiopatie waargeneem. Daar word voorgestel dat verhoogde
TNFa vlakke vir die hart nadelig is, ten spyte van die vermoeding dat die sitokien In
potensiële aanpassings rol by laer vlakke het.
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Doelstelling: Die doel van hierdie studie was om vas te stelof daar 'n verband tussen
vetsug en serum, miokardiale en vetweefsel TNFa vlakke en miokardiale hipertrofie,
bestaan. Ons het ook gepoog om te bepaal of harte van vetsugtige diere normaal
funksioneer en of die response van sulke harte op isgemie-herperfusie van die van
ooreenstemmende kontroles verskil.
Materiaal en tegnieke: Manlike Sprague-Dawley rotte (n=100) is vir 6-12 weke op 'n
hoë kalorie dieët (HKD) geplaas. Die HKD het uit 33% rotkos, 33% gekondenseerde
melk, 7% sukrose en 27% water bestaan. Kontrole diere het standaard laboratorium
rotkos ontvang. Voedselinname, liggaamsmassa toename, serum insulien, glukose
en lipied vlakke is ook bepaal. Harte is geïsoleer en geperfuseer volgens die Werk
Hart perfusie metode en hart funksie is gemonitor en gedokumenteer. Harte is
vervolgens aan 15 minute globale isgemie by 3rC blootgestel en daarna weer vir 30
minute geherperfuseer waartydens hartfunksie weer gedokumenteer is. 'n Aparte
groep harte is op spesifieke tydsintervalle gedurende die eksperimentele protokol
gevriesklamp en in vloeibare stikstof gestoor vir die bepaling van miokardiale TNFa
en sGMP vlakke.
Serum TNFa vlakke is bepaal na 12 weke op die dieët. Na die diere 12 weke op die
HKD was, is hierdie diere en hulooreenstemmende kontroles se miokardiale TNFa
vlakke voor en na isgemie bepaal. Vetweefsel en miokardiale TNFa vlakke is ook
onderskeidelik na 6, 9 en 12 weke bepaal. Miokardiale sGMP vlakke is in die HKD
diere en in die kontrole diere na 6, 9 en 12 weke bepaal. sGMP vlakke is gebruik as
'n indirekte indeks van aktivering van die miokardiale NO-sGMP boodskapper pad.
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Resultate: Na 12 weke op die dieët was die liggaamsmassa van die HKD diere
beduidend hoër in vergeleke met hulooreenstemmende kontroles (459.9 ± 173.8 g
en 271.5 ± 102.6 g (p<0.05)). Die HKD diere se hart massa tot liggaam massa
verhouding was ook beduidend hoër in vergelyking met die van kontroles (4.2 ± 0.1
mglg en 3.7 ± 0.1 mglg (p<0.05)).
Alhoewel insulien vlakke dieselfde was (12.42 ± 5.06 j.lIU/ml en 12.87 ± 1.02 j.lIU/ml),
was serum glukose vlakke van die HKD diere hoër as die van die ooreenstemmende
kontroles (9.2 ± 0.3 mmoiii en 7.8 ± 0.3 mmoiii (p<0.05)). Plasma lipied profiele (HOL
cholesterol, plasma cholesterol en trigliseriede) was abnormaal in die HKD diere.
Plasma TAG vlakke in die HKD diere was beduidend hoër as die van die kontroles
(0.664 ± 0.062 mmoiii en 0.503 ± 0.043 (p<0.05)), terwyl plasma cholesterol vlakke
(1.794 ± 0.058 mmoiii en 2.082 ± 0.062 mmoiii (p<0.05)) en HOL cholesterol vlakke
beduidend laer was (1.207 ± 0.031 mmoiii en 1.451 ± 0.050 mmoiii (p<0.05)).
Miokardiale meganiese funksie was dieselfde vir beide groepe voor isgemie, maar
die persentasie aorta omset herstel tydens herperfusie was laer in die HKD diere in
vergelyking met die van kontrole diere (47.86 ±. 7.87% en 66.67 ± 3.76% (p<0.05)).
Serum TNFa vlakke van die HKD diere was beduidend hoër as die van kontrole diere
(51.04 ± 5.14 AU en 31.46 ± 3.72 AU (p<0.05)), maar miokardiale TNFa vlakke was
laer (312.0 ± 44.7 pglgram nat gewig en 571.4 ± 132.9 pglgram nat gewig (p<0.05)).
Die vetweefsel TNFa vlakke was ook beduidend verhoog na 12 weke op "n hoë
kalorie dieët wanneer dit vergelyk word met die van kontrole diere (4.4 ± 0.4 pglgram
nat gewig en 2.5 ± 0.3 pglgram nat gewig respektiewelik (p<0.05)). Daar was
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geenbeduidende verskille in die miocardiale vlakke van sGMP in die HKD diere in
vergelyking met die kontroles na 6, 9 en 12 weke.
Gevolgtrekkings: 1) "n Hoë kalorie dieët het in dié studie vetsug geïnduseer en tot
miokardiale hipertrofie gelei. 2) Daar was "n positiewe korrelasie tussen verhoogde
vetweefsel en serum TNFa vlakke, en miokardiale hipertrofie. 3) Verhoogde serum
TNFa vlakke het nie tot die aktivering van die miokardiale NO-sGMP pad in hierdie
model gelei nie. 4) Die hipertrofiese harte het tydens herperfusie ná isgemie swakker
as hulooreenstemmende kontroles gefunksioneer.
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ABBREVIATIONS
Units of measurement
% percentage
1-11 microliter
I-1IU micro International Units
°C degrees Celsius
cm centimeters
g gram
gram ww gram wet weight
M molar
mg milligram
min minutes
mm millimeter
mmol millimole
mol mole
mW milliwatts
pg picogram
pmol picomol
v volume
w weight
Chemical Compounds
Ca2+ calcium
calciumchloride 2-hydrate
carbond ioxide
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KCI
KH2P04
MgS04·7H20
NaCI
NaHC03
°2
TRIS
water
potassium
potassium chloride
potassium dihydrogenphosphate
magnesiumsulphate 7-hydrate
sodium chloride
sodium hydrogen carbonate
Oxygen
tris(hydroxymethyl) aminomethane hydrochloride
Other abbreviations
Ab antibody
AC
ACE
ADP
ANG II
ANP
AD
AP-1
ASK1
ASP
ATP
AT-TNF
AU
BP
cAMP
adenylyl cyclase
angiotensin converting enzyme
aorta diastolic pressure
angiotensin II
atrial natriuretic peptide
aortic output
activating protein-1
apoptotic signal-regulated kinase 1
aorta systolic pressure
adenosine triphosphate
adipose tissue-derived TNF
arbitrary units
blood pressure
cyclic 3' ,5'-adenosine monophosphate
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CAM
CF
cGMP
CHF
CN
CoA
CT-1
DAG
OIO
DNA
ECM
ELISA
eNOS
ERK
ET-1
FAD
FADO
FAK
FFA
FMN
FRAP
GOP
gp130
G-protein
GTP
HCD
calmodulin
coronary flow
cyclic 3',5'-guanosine monophosphate
congestive heart failure
calcineurin
coenzyme-A
cardiotrophin-1
diacylglycerol
diet induced obesity
deoxyribonucleic acid
extracellular matrix
enzyme-linked immunosorbent assay
endothelial NOS
extracellular-regulated kinases
endothelin-1
flavine adenine nucleotide
Fas-associated death domain
focal adhesion kinase
free fatty acids
flavin mononucleotide
FKBP-12-rapamycin associated protein
guanosine diphosphate
glycoprotein 130
guanine nucleotide-binding proteins
guanosine triphosphate
high caloric diet
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HDL
HR
I-KB
IE genes
IL-p
IL-6
INFy
iNOS
IP3
JAK
JNK
LDL
L-NAME
LPL
MADD
MAPK
MAPKAP
MEK
MEK
MHC
MLC
Mort 1
mRNA
NADPH
N
NEFA
high density lipoprotein
heart rate
inhibitory-KB
immediate early genes
interleukin-beta
interleukin-6
interferon-gamma
inducible nitric oxide synthase
inositol-triphosphate
janus-associated kinases
c-Jun N-terminal protein kinases
low density lipoprotein
W-nitro-L-arginine methyl ester
lipoprotein lipase
mitogen-activated protein kinase-activating death domain
mitogen-activated protein kinases
MAPK-associated protein kinase
MAPKlERK
MEK kinases
myosin heavy chain
myosin light chain
mediator of receptor induced toxicity (alternative for FADD)
messenger ribonucleic acid
nicotinamide adenine dinucleotide phosphate-reduced form
Normal
non-esterified fatty acids
xv
Stellenbosch University http://scholar.sun.ac.za
NF/AT
NF-KB
NIK
nNOS
NO
NOS
PDE
PIP2
PKA
PKC
PKG
PLA
PlB
PlC
PlD
RIP
RNA
ROl
ROS
SAC
SAPK
SEM
SERCA
sGC
SHR
SMase
nuclear factor of activated T-lymphocytes
nuclear factor-kappa B
NF-KB inducing kinase
neural NOS
nitric oxide
nitric oxide synthase
phosphodiesterase
phosphatidyl inositol-bisphosphate
cAMP dependent protein kinase activity
protein kinase C
cGMP dependent protein kinase
phospholipase A2
phospholamban
phospholipase C
phospholipase D
receptor interacting protein
ribonucleic acid
reactive oxygen intermediates
reactive oxygen species
stretch activated ion channels
stress activated protein kinases
standard error of the mean
sarcoplasmic reticulum Ca2+ ATPase
soluble guanylyl cyclase
spontaneously hypertensive rats
sphingomyelinase
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STAT
sTNF-R
TAG
TGF-p
THB4
TNF-a
TNF-R
TRADD
TRAF-1
TRAF-2
VEGF
Wt
signal transducers and activators of transcription
soluble TNF-receptors
triacylglyceride
transforming growth factor-beta
tetrahydrobiopterin
tumor necrosis factor-alpha
TNF-receptors
TNF receptor-associated death domain
TNF receptor-associated factor 1
TNF receptor-associated factor 2
vascular endothelial growth factor
total work
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Chapter 1
INTRODUCTION
Cardiac hypertrophy is an adaptive process that occurs in response to mechanical
overload or tissue injury. It is characterized by increased myocyte size, proliferation
of cardiac fibroblasts and progression of interstitial and perivascular fibrosis. The
stimuli for cardiac hypertrophy are diverse and vary from increased afterload on the
heart to cardiac remodeling in response to cytokines (Chiariello and Perrone-Filardi,
1999).
Pressure overload induces pathological hypertrophy with impairment in systolic
function, myocardial relaxation and an increase in diastolic stiffness (Lecarpentier et
eï. 1987; Doering et a/·, 1988). The diastolic stiffness is accounted for by an increase
in interstitial collagen (Doering et el-. 1988; 8rilla et el-, 1991). These changes also
represent an initial step in the pathogenesis of many cardiac diseases that ultimately
progress to ventricular failure. The mechanisms by which this condition of cardiac
hypertrophy eventually progresses to heart failure are not fully understood.
Hypertrophied hearts are more vulnerable to brief periods of ischaemia because of
an impaired reactive hyperaemic response, which results in a delayed metabolic
recovery (McAinsh et eï. 1998). These abnormalities may contribute to the increased
morbidity that is associated with cardiac hypertrophy (McAinsh et a/., 1998).
Hypertrophy has been conceptualized as possibly having two components, mediated
by cardiac myocytes (MC) and nonmyocytes (NMC) (Kuwahara et a/., 1999).
Interaction between MC's and surrounding NMC's is likely to be an important
1
Stellenbosch University http://scholar.sun.ac.za
component of the hypertrophic process (Weber and Brilla, 1991). Many growth
factors and cytokines acting as autocrine/paracrine factors are probably involved in
the response and cross talk between MC and NMC. These routes appear to play an
important role in the pathophysiology of cardiac hypertrophy.
Obesity has been linked to left ventricular hypertrophy and is a metabolic disorder in
which multiple clinical and biochemical alterations coexist. Abnormal carbohydrate
and lipid profiles are features that are usually present in the obese individual. They
usually have elevated triglycerides, total cholesterol, and low-density lipoprotein
cholesterol levels and reduced high-density lipoprotein cholesterol concentrations
(Kannel et eï-. 1971; LaRosa et aI., 1990). Due to the excessive weight associated
with obesity, the overall metabolic demands are elevated, and in order to deliver
more oxygen to the peripheral tissue, the cardiac output is increased. In this case
increased stroke volume accounts for the increased cardiac output. Blood volume is
also increased, due to increased tissue volume and vascularity. With time, the
obesity induced increase in preload on the heart results in left ventricular hypertrophy
and dilatation (Paulson and Tahiliani, 1992).
Hypertrophic obesity (maturity-onset obesity) is the predominant type of obesity
present in man, and is associated with complications such as hypertension, insulin
resistance and impaired glucose metabolism (Paulson and Tahiliani, 1992). It is
difficult to implicate obesity directly to cardiovascular disease, because obesity
usually coexists with a number of secondary cardiovascular risk factors such as the
diabetes, hypercholesterolemia and hypertension just mentioned.
Recent research findings have shown that serum TNFa levels are elevated in obese
2
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individuals and it has been proposed that these cytokines may playa role in cardiac
remodeling. The heart is a major cytokine-producing organ that generates TNFa.
Both myocardial macrophages and cardiac myocytes are known to synthesize this
proinflammatory cytokine, which acts to increase its own production and the
synthesis of small inflammatory mediators such as platelet activating factor,
eicosanoides and oxidative radicals. TNFa has cytostatic and cytotoxic effects on
certain tumor cells, influencing growth and differentiation in virtually every cell type,
including cardiomyocytes. TNFa is also an endogenous pyrogen that stimulates the
production of other endogenous pyrogens, such as interleukin-p (IL-p) (Meldrum,
1998). Adipose tissue is another strong source of TNFa and has been implicated in
the elevation of circulating TNFa levels and endothelial dysfunction (Yudkin et eï-.
1999).
Elevated levels of TNFa are detected peripherally in almost all forms of cardiac injury
as well as hypertrophic cardiomyopathy (Matsumori et el-. 1994). Elevated
myocardial TNFa levels are deleterious to the heart, although a beneficial and
adaptive role has also been proposed (Nakano et el-. 1998). The short-term
expression of myocardial TNFa, and possibly other cytokines such as IL-p and
cardiotrophin-1 (CT-1) may provide the heart with additional homeostatic responses
to environmental stress. These may include hypertrophic growth, increased regional
myocardial blood flow and increased resistance to ischaemia-induced arrythmias
through the generation of nitric oxide (Yokoyama et el-. 1997).
It may be possible that elevations in serum TNFa levels induces iNaS and leads to
decreased mechanical function of the heart of obese individuals. iNaS is the cytokine
inducible isoform of nitric oxide synthase (NOS), which is expressed by a number of
3
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paranchymal cells within the myocardium, including the endothelium of the coronary
microvasculature and the myocardium. Infiltrating inflammatory cells are all able to
express iNOS in response to soluble inflammatory mediators including specific
cytokines and bacterial cell wall components (Balligand et eï-. 1993; Balligand et eï-.
1995). iNOS induction has been demonstrated to diminish both basal and
catecholamine enhanced chronotropic and inotropic function in isolated myocytes
and in the intact heart (Ungureanu-Longrois et el-, 1995). The mechanisms by which
NO mediates these effects include increased activation of soluble guanylyl cyclase
(sGC) causing elevated cGMP levels (Kinugawa et al., 1997), inhibition of electron
transport by mitochondrial respiratory chain, and the production of oxidants, such as
peroxynitrite (Beckman and Koppenol 1996). At low physiological concentrations NO
may protect the myocytes from harmful stimuli such as mechanical stress or
norepinephrine. At higher physiological levels it may not only decrease function, but
also cause the loss of myocytes due to apotosis (Sawyer and Colucci, 1998).
It remains controversial whether cardiac hypertrophy results solely from the blood
volume overload associated with obesity. Since cytokines are thought to be involved
in cardiac remodeling and playa role in certain forms of cardiac hypertrophy, we
wished to determine whether these paracrine/autocrine factors, and in particular
TNFa, may be involved in stimulating cardiac hypertrophy in obesity. This is
particularly important, as obesity has been associated with chronic elevations in
serum TNFa levels (Yudkin et el-, 1999). This study was therefore designed to
investigate whether there is a possible link between myocardial TNFa levels, adipose
tissue TNFa levels, serum TNFa levels, and myocardial hypertrophy. We also wished
to investigate whether the elevated TNFa levels in the obese animals had direct
effects on cardiac function and the severity of ischaemia/reperfusion injury.
4
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Chapter 2
LITERATURE REVIEW
2.1 Cardiac Hypertrophy
Cardiac hypertrophy is a fundamental process of adaptation to an increased
workload due to hemodynamic overload, such as increased blood pressure and/or
blood volume (Cooper, 1987; Mondry and Swynghedauw, 1995). Myocardial
hypertrophy is defined as an increased myocardial mass beyond the normal range.
The upper heart weight limit for men is 450 grams while that for women is 400 grams.
The development of cardiac hypertrophy is initially compensatory and therefore
beneficial. This period occurs when the work-induced growth of the heart
compensates for the increased workload per heart mass ratio. Gross mechanical
function is normal, but sensitive tests shows a decreased rate of shortening velocity,
delayed relaxation, and a diminished coronary vascular reserve (Meerson, 1983).
Hypertrophy augments the number of contractile units and reduces ventricular wall
stress to normal levels, following the law of Laplace, whereby an increased wall
thickness decreases wall stress. Many of the key proteins involved in cardiac function
undergo changes of qualitative and quantitative nature in response to hemodynamic
overload (Lompre et el-. 1991). Therefore the adult heart adapts to a superimposed
environmental stress by three interrelated and integrated mechanisms, namely
cardiac hypertrophy, cardiac remodeling and cardiac repair (Mann, 1996).
Compensated hypertrophy often progresses to decompensated cardiac hypertrophy.
This condition occurs when the work output per unit of cardiac mass decreases. This
is usually due to the progressively decreasing ability of the heart to fill normally and to
generate force (Meerson, 1983).
5
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The hypertrophy of cardiomyocytes is initiated by endocrine, paracrine, and autocrine
factors that stimulate a wide array of membrane bound receptors. Their activation
results in the triggering of multiple cytoplasmic signal transduction cascades, which
affects nuclear factors and the regulation of gene expression.
The functional changes during the development of cardiac hypertrophy include
impairment in systolic function, myocardial relaxation and an increase in diastolic
stiffness (lecarpentier et eï. 1987; Doering et el-. 1988). Abnormalities in diastolic
relaxation and systolic function are thought to be due to the down-regulation of
intracellular calcium handling proteins such as the sarcoplasmic reticulum Ca2+-
ATPase (SERCA) and phospholamban (PlB). SERCA fascilitates the transport of
Ca2+ into the sarcoplasmic reticulum, while the phosphorylation of PlB increases the
affinity of SERCA for Ca2+. Besides changes in the status of functional proteins an
increase in interstitial collagen and other structural proteins has also been shown to
account for the increase in diastolic stiffness in cardiac hypertrophy (Doering et et-,
1988; Brilla et el-. 1991).
During the development of cardiac hypertrophy specific changes have been
observed in cardiomyocytes, namely rapid induction of proto-oncogenes and heat
shock protein genes, quantitative and qualitative changes in gene expression, and
increased rate of protein synthesis. The first response to hemodynamic overload is
the induction of proto-oncogenes such as c-fos, c-jun and c-myc, and heat shock
protein gene hsp70, collectively called immediate-early (IE) genes (Mulvagh et el-.
1987; Komuro et el-. 1988; Izumo et el-, 1988).
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With hypertrophy the expression of several genes that encode sarcomeric proteins
are switched to expression of fetal isoforms, such as the transition from cardiac a-
actin to skeletal a-actin and from the a-form of myosin heavy chain (MHC) to the ~-
MHC form in rodents (Schwartz ef al., 1986). In addition several shifts in isogene
expression of proteins involved in energy metabolism have been described (Revis ef
el-, 1977; Meerson and Javich, 1982). Atrial natriuretic peptide (ANP), which is
restricted to the atria until shortly after birth, is also re-expressed in the ventricle upon
hemodynamic overload (Izumo ef eï. 1988).
2.1.1 Stimuli causing cardiac hypertrophy
Mechanical stress and neural or humoral factors
The primary stimuli for cardiac hypertrophy are mechanical stress and/or an
accompanying increase in neural or humoral factors. Yet cardiac hypertrophy can be
induced even after adrenoreceptor blockade (humoral) or sympathectomy (neural)
(Cooper ef al., 1985). Thus mechanical stress by itself induces cardiac hypertrophy in
response to hemodynamic overload. This view is supported by several studies done
in vivo and in vitro- In the isolated heart, increased cardiac load stimulated protein
synthesis (Kira ef el-. 1984) and stretching cultured cardiac myocytes stimulated
protein synthesis and induced alterations in gene expression without involvement of
humoral factors (Mann ef eï-. 1989; Komuro ef al·, 1990; Sadoshima ef el-, 1992; Kira
ef el-, 1994; Vandenburgh ef et-. 1995).
Other stimuli such as growth factors and hormones have been implicated in the
induction of cardiac hypertrophy. The expression or release of these factors have
been reported in hearts that are hypertrophied due to hemodynamic overload and in
cardiomyocytes that are hypertrophied due to stretch (Ruwhof and Van der Laarse,
7
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2000). These factors include endothelin-1 (ET-1) (Arai et el-. 1995) angiotensin II
(ANG II) (Sadoshima and Izumo, 1993; Miyata et et-. 1996; Tamura et eï-. 1998),
transforming growth facter-g (TGF-~) (Villareal and Dillman, 1992; Calderone et el-.
1995), insulln-like growth factor-1 (IGF-1) (Calderone et et-. 1995), myotrophin (Sen
et st-. 1990) and vascular endothelial growth factor (VEGF) (Li et al., 1997a; Seko et
el-. 1999). Cardiac myocytes, cardiac fibroblasts, endothelial cells and vascular
smooth muscle cells, all possibly secrete growth promoting factors after a mechanical
stress stimulus, which induce hypertrophy of cardiomyocytes in an
autocrine/paracrine fashion (Ruwhof and Van der Laarse 2000).
There are mechanosensors such as integrins and the cytoskeleton, and sarcolemmal
proteins that are also implicated in cardiac hypertrophy. Integrins are a family of cell-
surface receptors that link the extracellular matrix (ECM) to the cellular cytoskeleton
at sites called focal adhesion sites (Hynes, 1992; Juliano and Haskill, 1993; Schwartz
et el-. 1995).
Integrins are composed of a and ~ subunit heterodimers that consist of a large
extracellular domain, a transmembrane region, and usually a short cytoplasmic
domain. The extracellular domain binds to proteins of the ECM or to counter-
receptors on other cells, whereas the cytoplasmic domain forms links with
cytoskeletal proteins and intracellular signaling molecules such as a-actinin and focal
adhesion kinase (FAK) (Hynes, 1992; Lewis and Schwartz, 1995). Integrins can act
as mechanotransducers in cardiac cells (MacKenna et al., 1998), since cardiac
fibroblasts caused activation of two signal transduction pathways, the ERK and JNK
pathway once the fibroblasts were stretched in an integrin (~1)-dependent manner.
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Studies have confirmed the influence of integrins in the hypertrophic response in
cardiomyocytes (Ross et el-. 1998).
Mechanical stress may also cause deformation of the sarcolemma, which may
directly or indirectly induce conformational changes in proteins that are anchored to
the inner surface of the cell membranes, or in transmembrane proteins. Sarcolemmal
proteins include several effector enzymes such as phospholipases and protein kinase
C (PKC) isoenzymes, ion channels such as stretch-activated channel (SAC), or ion
exchangers such as the Na+/H+exchanger (Ruwhof and Van der Laarse, 2000).
Protein kinase C and cardiac hypertrophy
Phospholipases are enzymes that catalyze the breakdown of plasma membrane
phospholipids, thereby generating second messenger molecules. Activated PLC can
hydrolyze phosphatidylinositol-bisphophate (PIP2) into inositol-triphosphate (IP3) and
diacylglycerol (DAG). DAG is a second messenger that causes the translocation of
PKC isoenzymes from the cytosol to a membrane fraction, thereby activating them
(Newton, 1995). Activation of PKC may then reduce the action of PLC and stimulate
that of PLD (Nishizuka, 1992). Experimental evidence suggests that the activation of
PLC and/or PLD may playa role in mechanical stress-induced cardiac hypertrophy
(Von Harsdorf et et-. 1989; Sadoshima and Izumo, 1993; Dassouli et et.. 1993).
Protein kinase C (PKC) is a serine/ threonine protein kinase. The PKC family consists
of several isoenzymes that differ in distribution, regulation, and enzyme activity. The
isoenzymes are classified into three subclasses, namely the classical PKCs which
are regulated by DAG, phosphatidylserine, and Ca2+; novel PKCs which are
regulated by DAG and phosphatidylserine, but not Ca2+, and finally the atypical PKCs
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whose regulation has to be defined although DAG and Ca2+ appear not to be
involved (Puceat and Vassort, 1996; Newton, 1997). Activation of PKC in
cardiomyocytes has been found to stimulate the expression of c-fos and skeletal a-
actin genes (Komuro et aI., 1991) and to activate transcription of p-MHC, MLC-IIa,
and ANP (Kariya et el-. 1991; Shubeita et aL, 1992) indicating that activation of PKC
can induce hypertrophy.
Mechanosensitive ion channels and cardiac hypertrophy
Activation of mechanosensitive ion channels has been observed to be involved in the
transduction mechanism between mechanical stress and cardiac hypertrophy (Hu
and Sachs, 1997). The passage of Nat, K+ and Ca2+ is allowed through these stretch
activated ion channels (SACs) (Ruknudin et eï. 1993). Several mechanisms for Ca2+
involvement in the development of cardiac hypertrophy have been proposed
(Ruknudin et el-. 1993). Increased concentrations of Ca2+ may enhance the PKC
activity followed by direct or indirect alterations in gene expression. Ca2+ can also
regulate IE gene expression, such as c-fos (Rosen et aI., 1995).
Activation of Na+/H+ exchanger has also been implicated in the process of
mechanotransduction through the SACs, since its activation increases intracellular
pH, which is known to stimulate the expression of hypertrophic marker genes and
protein synthesis (Fuller, 1997).
G-proteins and cardiac hypertrophy
Another candidate mechanism for mechanotransduction involves guanine nucleotide-
binding proteins (G-proteins) that couple cell surface receptors to the appropriate
effectors. There are two forms of signal transducing G-proteins, the small G-proteins
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and the heterotrimeric G-proteins. These G-proteins share common characteristics:
they exist in two interconvertible conformational states, i.e. an inactive guanosine
diphosphate (GDP)-bound state and an inactive guanosine triphosphate (GTP)-
bound state (Hall, 1990). The heterotrimeric G-proteins are associated with signal
transduction originating from cell surface receptors. Heterotrimeric G-protein subunits
are localized at sites of focal adhesions that provide contact via integrins with ECM
thereby functioning as a sensor of mechanical stress (Hansen et al., 1994).
Activation of PKC may be crucial in this G-protein induced hypertrophy. Therefore it
has been hypothesized that integrins, heterotrimeric G-proteins, PLC and PKC have
an integrated action in the mechanotransduction of cardiac hypertrophy (Molkentin et
et-, 1998; Mende et et-, 1999).
2.1.2 Signal transduction pathways in cardiac hypertrophy
The signal transduction pathways possibly involved in the mechanical stress-induced
hypertrophy include two major pathways, the mitogen-activated protein kinases
(MAPK) pathway and the janus-associated kinases /signal transducers and activators
of transcription (JAKISTAT)- pathway.
The MAPKs are serine/threonine kinases that become activated upon
tyrosine/threonine phosphorylation and additional modifications, and they in turn
phosphorylate and activate nuclear substrates such as c-myc, c-jun, ATF-2, and
p62TCF and other kinases such as p90RSK and MAPKAP kinase 2 (Sturgill and Wu,
1991; Dalby et el-. 1998). This pathway consists of several subfamilies of which the
extracellular-regulated kinases (ERK) pathway, the c-Jun N-terminal protein kinases
(JNK) pathway and the p38 MAPK pathway are perhaps the most important. They
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are activated by heterotrimeric G proteins, such as Ras, cdc42, Rac, by protein
kinases such as Src and FAK and by PKC via activation of PLC and/or PLO or by
JAKs via gp130. Their downstream targets are cytosolic kinases such as p90RSK and
MAPKAPK2/3 and nuclear transcription factors such as c-jun, c-myc and Elk1
(Ruwhof and Van der Laarse, 2000). The JAK/STAT pathway is directly activated
probably via gp130. Upon activation of STATs by JAKs, STATs translocate to the
nucleus and induce gene transcription (Ruwhof and Van der Laarse, 2000).
Cardiac hypertrophy can also be induced by the Ca2+/calmodulin-dependent
phosphatase calcineurin (Molkentin et eï-, 1998). Studies on transgenic mice
expressing activated forms of calcineurin developed cardiac hypertrophy, and upon
cyclosporine (an inhibitor of calcineurin) administration, cardiac hypertrophy was
prevented in these mice (Molkentin et aI., 1998). Cyclosporine not only inhibited
calcineurin, but also suppressed the re-expression of fetal genes in cardiomyocytes
when stimulated in vitro with Ang " and phenylephrine. Activation of calcineurin
dephosphorylates the cytoplasmic transcription factor NF-AT3, which migrates into
the nucleus and interacts with the GATA4 transcription factor to synergistically up-
regulate gene expression (Molkentin et aI., 1998).
However, other studies failed to show that cyclosporine suppresses the development
of cardiac hypertrophy in rodents with hemodynamic overload in vivo (Zhang et el-,
1999a; Ding et el-. 1999). The involvement of calcineurin in the development of
hypertrophy is therefore still controversial (Molkentin et et.. 1998; Ruwhof and Van
der Laarse, 2000) (Figure 2.1.1).
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Figure 2.1.1: Signal transduction via the calcineurin and p70 S6 kinase pathway.
Activation of each of these pathways has been linked to cardiac hypertrophy. CN,
calcineurin; FRAP, FKBP-12-rapamycin associated protein; CAM, calmodulin; NF/AT,
nuclear factor of activated T-Iymphocytes. (Adapted from Boluyt and Bing, 2000)
2.1.3 Transition from cardiac hypertrophy to heart failure
Impaired functional performance despite hypertrophic enlargement characterizes the
decompensated failing heart. Features of heart failure include depressed myocardial
function, extensive interstitial fibrosis, and apoptotic myocyte loss (Bing et et.. 1995;
Conrad et et.. 1995; Li et al·, 1997b). In fact, interstitial fibrosis is a hallmark of
cardiac hypertrophy in heart failure (Anderson et el-. 1979; Pearlman et el, 1982;
Huysman et al·, 1989) and other pathological conditions such as dilated
cardiomyopathy (Beltrami et al., 1995) as well as in aging (Besse et el-. 1994; Boluyt
et aJ., 1994). Manifestations of decompensated function include ventricular dilatation,
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reduced fractional shortening, diminished ejection fraction, and decreased myocardial
force production.
Several factors have been suggested to play roles in the transition from compensated
hypertrophy to the decompensated state. These include abnormalities in: (i) calcium
handling (Feldman et eï-. 1993), (ii) contractile proteins (Boluyt et el-. 1994), and (iii)
extracellular matrix proteins (Boluyt et et. 1994). As previously mentioned, myocyte
hypertrophy is not only modulated by loading conditions, but also by systemic or
neurohormonal processes (Dzau, 1993). The cardiac renin-angiotensin system is
activated in the pressure-overloaded heart (Zhang et al., 1995), and has been shown
to play a deleterious role in the transition toward congestive heart failure (CHF)
(Litwin et al., 1995). The expression of chemokines and pro-inflammatory cytokines
also play a role in the development of hypertrophy and eventually cardiac failure
(Feron et el-. 1995). Oxidative stress, which is induced by pro-inflammatory
cytokines, is also involved in the process (Schreck et et-. 1991; Dhalla et al., 1996).
Age-associated changes in the myocardium also contribute to the progression from
stable cardiac hypertrophy to dysfunction and heart failure (Kannel and Belanger,
1991). Fibronectin is an integral protein of the extracellular matrix that acts to bind
together various components of the heart. The levels of fibronectin mRNA decreases
between development and adulthood (Mamuya et el-. 1992). Yet the levels of this
protein are increased again in the aging left ventricle (LV) and atria (Boluyt and
l.akatta, 1998).
Fibrosis increases the stiffness of the myocardium leading to diastolic dysfunction
and exacerbation of heart failure (Weber et el-. 1993). Fibrosis results, in part, from
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the increased expression of genes encoding extracellular matrix proteins that make
up the scaffolding that provides the framework in which myocytes function (Boluyt
and Bing, 2000).
In a study on spontaneously hypertensive rats (SHR), the transition to heart failure is
accompanied by marked changes in the expression of an array of genes in the heart.
Amid the most prominant changes are increased levels of mRNAs encoding
fibronectin, collagen Type I, collagen Type III and osteopontin, which are all
components of the extracellular matrix (Boluyt et eï. 1994; Singh et el-, 1999).
Interstitial and perivascular localization of collagen mRNA has been implicated in
failing hearts (Bing et al., 1997), and since increases in fibrillar collagen in the
interstitium contributes to tissue stiffness, increases in fibronectin and collagen gene
expressions are likely to contribute to the impaired function. The strong relationship
between fibrosis and myocardial stiffness is very well demonstrated in studies where
an angiotensin converting enzyme (ACE) inhibitor was used to treat young adult SHR
in dosages allowing the dissociation of hypertrophy and fibrosis. The experiments
demonstrated that the ACE inhibitor could regress fibrosis and normalize LV stiffness
in the aged SHR, thereby preventing LV dysfunction (Brilla et al., 1996).
Other studies have demonstrated that the transforming growth factor P1 (TGFp1)
family of cytokines plays a key role in regulating many aspects of the remodeling
process including the up-regulation of extracellular matrix (ECM) genes (Boluyt et al.,
1994). The up-regulation of TGFp1 gene expression observed in failing hearts may be
involved in controlling accumulation of extracellular matrix, as seen during wound
repair (Zhang et el-. 1999b). Fibrosis and collagen formation were reduced in a study
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done where TGFp1 was inhibited (Smith et al., 1999). TNFa and its role in the
decompensated heart will be discussed later.
2.2 Obesity
Obesity essentially results from an imbalance between food intake and energy
utilization. The condition is usually characterized by a large increase in adipose
tissue and its triglyceride content. This increase in adipose tissue may be partly due
to ani increase in the number of adipose cells (termed hyperplastic obesity) or an
increase in size of the adipose tissue (termed hypertrophic obesity). Obesity is
normally associated with a number of secondary conditions, including hypertension,
abnormal lipid metabolism and insulin resistance leading to impaired glucose
tolerance or type II diabetes mellitus. These conditions are all cardiovascular risk
factors known to have an adverse effect on the cardiovascular system (Paulson and
Tahiliani, 1992).
Increasing adiposity as a function of increasing age also contributes to the increase
in the incidence of diabetes and hypertension, which are both cardiovascular risk
factors (Holbrook et el-. 1989; Caro, 1991; Busby et el-, 1992; Coldritz et el-. 1995).
Although the specific cause for obesity is unknown, abnormalities in leptin
homeostasis have been proposed to increase the propensity of obesity (Caro et aL,
1996). Leptin is released into the plasma (Frederich et al., 1995; Leroy et el-, 1996)
and the concentrations are related to body fat mass (Frederich et et-. 1995).
Development of obesity in some rodent models is related to mutations in leptin or the
leptin receptor. Administration of leptin to obese rats lacking leptin result in immediate
normalization of body weight, metabolism and the regulation of the hypothalamic-
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pituary axis (Caro et al., 1996). The role of leptin in humans however remains unclear
(Widdowson et el-. 1997).
2.2.1 Obesity and cardiac remodeling
Due to the excessive weight associated with obesity the overall metabolic demands,
including oxygen consumption, are increased. In order to deliver more oxygen to
peripheral tissues, cardiac output is increased. An increased stroke volume rather
than heart rate accounts for the increase in cardiac output (Garavaglia et el-, 1988).
The increased stroke volume is achieved by an augmented end-diastolic volume and
increased pre-load. Both these parameters increase due to the increase in blood
volume associated with obesity. Blood volume is also increased because of the
increased peripheral vascularity (Messerli, 1982). Over an extended period this
elevated pre-load on the heart results in left ventricular hypertrophy and eventually
dilatation. Other factors may also be involved in cardiac remodeling such as TNFa,
which is released by adipose tissue and/or produced de novo in the heart
(Hotamisligil et el-, 1994; Kapadia et eï-. 1997).
2.2.2 Obesity and insulin resistance
Insulin resistance occurs when there is a decreased tissue responsiveness to insulin
in the body. Insulin resistance has been associated with pathologic conditions such
as diabetes (both type I and type II), hypertension and coronary heart disease
(Ferrannini and Natali, 1991). Visceral adiposity appears to be a strong risk factor for
hypertension, dyslipidemia, coronary heart disease and insulin resistance of type II
diabetes in various species (Pouliot et el-. 1992; Spiegelman et al., 1992; Tschernof
et et-. 1996; Banerji et eï-. 1997). Furthermore, in clinical studies, detectable cardiac
dysfunction has been reported to occur as early as the glucose intolerance phase
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that follows insulin resistance (Celentano et a/., 1995). Diabetic-like cardiomyopathy
has also been demonstrated at very early stages of type II diabetes and is therefore
associated with insulin resistance (Dutta et eï-. 2001).
Diabetes is a principle cause of morbidity and mortality in human populations. Only a
small population of patients suffer from type I diabetes, which is caused by pancreatic
~-cell failure and leads to an absolute loss of insulin (Nathan, 1993). Type II diabetes
mellitus is characterized by target-tissue resistance to insulin and cannot be
overcome by ~-cell hypersecretion (Taylor, 1999).
Although type II diabetes mellitus is associated with insulin resistance, in both rodent
and human models, the connection between increased adiposity and insulin
resistance remains unclear (Kahn et a/., 1996; Kopelman, 2000).
The mechanisms for the decreased insulin responsiveness in obese individuals is
unknown. Adipocytes however secrete a variety of other polypeptides, such as tumor
necrosis factor-a (TNFa), adipsin, Acrp 30/adipoQ and resistin, that may affect
insulin action in other tissues (Spiegelman and Flier, 1996; Mohamed-Ali et al. 1998;
Friedman and Halaas, 1998; Hotamisligil, 1999; Shimomura et el.. 1999; Moller,
2000; Steppan et a/., 2001). Insulin resistance in persons with visceral obesity may
relate in part to the metabolic characteristics of visceral fat cells, which when
compared with peripheral fat cells, are more resistant to the metabolic effects of
insulin and more sensitive to lipolytic hormones (Tandia et a/., 1989; Jensen et el-.
1989). The preferential channeling of different fuels to fat and changes in the
transcription profile of adipose tissue remain poorly understood in the pathogenesis
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of obesity and insulin resistance. Carbohydrate and lipid metabolism play an
important role in this context (Fabris et et-. 2001).
Carbohydrates and lipids share common pathways, which may be important in the
regulation of energy metabolism and fuel partitioning. Insulin stimulates glucose
oxidation in skeletal muscle and adipose tissue, but other macronutrients, which
increase may interfere with glucose oxidation (Ferrannini et al., 1983). Free fatty acid
(non-esterified fatty acid [NEFA])-induced insulin resistance saves scarce glucose for
central nervous system requirements, and this becomes counterproductive in obesity
because it inhibits glucose utilization when there is no need to save it (Fabris et el-,
2001). Glucose and NEFA might thus be channeled toward adipose tissue in which
insulin sensitivity is maintained or improved, and contribute to triglyceride synthesis,
although the cellular and molecular mechanisms are still under debate.
2.3 TNFa
Tumor necrosis factor a is the term originally used to describe a humoral factor that
was released by activated macrophages and induced hemorrhagic necrosis of
transplanted tumors in mice (Carswell et el-, 1975). TNFa is now recognized as a
cytokine (general term for protein intercellular messengers that influence cells of the
immune system) with pleiotropic biological capabilities. Besides its cytostatic and
cytotoxic effects on certain tumor cells, TNFa influences growth, differentiation and
function of virtually every cell including cardiac myocytes (Gulick et et-. 1989;
Yokoyama et et-. 1993). Thus, TNFa is part of an integral network of interactive
signal pathways that orchestrate inflammatory and immunological events.
TNFa is expressed as a 26 kDa cell surface transmembrane protein; cleavage by
TNFa converting enzyme generates a 17 kDa soluble form of TNFa, which is thought
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to mediate most of its biological effects. Two distinct membrane receptors, a 55 kDa
isoform (p55) and a 75 kDa isoform (p75) mediate all actions of TNFa (Moller, 2000).
TNFa binds to these two specific cell surface receptors, namely type 1 (p55) and
type 2 (p75) or termed TNF-R55 and TNF-R75. The extracellular portions of the TNF
receptors have been identified in the serum in soluble forms (sTNF-Rs). Endogenous
formation of TNFa and release causes shedding of the extracellular portion (sTNF-
Rs). sTNFa-Rs will now compete with the membrane bound receptors for the
released TNFa, interfering with the binding of TNFa to cell-surface bound TNF-Rs.
Therefore the sTNF-R concentration reflects the activation state of the TNFalTNF
receptor system (Zahorska-Markiewicz et el-, 2000), (Figure 2.3.1).
2.3.2 TNFg, and the heart
It has been observed that elevated levels of TNFa are detected peripherally in almost
all forms of cardiac injury, including cardiac allograft rejection (Arbustini et el-, 1991;
Sakobar et al·, 1993), myocardial infarction (Maury and Teppo, 1989; Basaran et el-,
1993), myocardial reperfusion injury (Lefer et el-. 1990; Herskowitz et aJ., 1995)
hypertrophic cardiomyopathy (Matsumori et el-. 1994) and end stage congestive
heart failure (Levine et eï-. 1990; Dutka et el-. 1993).
The observation that TNFa gene expression is also linked to almost all forms of injury
suggests that it may serve as a 'stress response' gene in the heart (Mann, 1996).
TNF a is expressed de novo in the heart within 30 minutes after a stressful stimulus
(Kapadia et al., 1995). TNFa mRNA levels rapidly return towards baseline levels
once the stressful stimulus is removed, hence suggesting that TNFa gene expression
is tightly regulated in the heart (Kapadia et el-. 1995).
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Figure 2.3.1: Cytokine bioactivity. When soluble TNF a receptors are bound to TNFU'
they are capable of preventing TNF a from binding to the TNF a receptors on the cell
surface membranes. (Modified from Bozkurt et el. 1998).
Since TNF a is a mediator of inflammation and septic shock, its effects are
considered as harmful or beneficial to the host. It triggers the release of practically all
known mediators of inflammation such as other cytokines and all metabolites of
arachidonic acid, the final results ranging from haemorrhagic necrosis to extensive
local fibrosis (Aggarwal and Natarajan, 1996).
TNF a can also initiate its own transcription and induce self-amplification (Ferrari,
1998). It damages the host by inducing and enhancing, often in association with
IFN-y' the production of reactive oxygen derivatives, such as nitric oxide. However
under these pathological conditions, TNFa may have dual effects, allowing the host
self-protection against this type of injury by the induction of oxygen free radical-
scavenging enzymes, such as mitochondrial superoxide dismutase and of protective
substances such as heat shock proteins (Aggarwal and Natarajan, 1996).
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The bi-functional effects TNFa are thought to be dependent on concentrations of its
expression in the myocardium. This cytokine is harmful to the myocardium when
expressed in high concentrations, causing left ventricular dysfunction and apoptosis
(Kubota et et. 1997).
However, acute exposure of the heart to low levels of TNFa may be cardioprotective.
Sack and colleagues (2000) have proposed that post-ischaemic recovery was
improved by acute/subacute low concentrations of TNFa in the isolated rat heart. On
the other hand inhibition of the synthesis of TNFa by an inhibitor of p38 MAP kinase
decreased the production of this cytokine and improved post-ischaemic function
(Cain et el-. 1999) (Figure 2.3.2.1). The different results observed in these studies
may be due to differences in the method of induction of ischaemia, the duration of
ischaemia and the species used in the studies (Sack et el-. 2000).
2.3.3 TNF£! and cardiac hypertrophy
Clinical studies show that circulating levels of TNFa are elevated in patients with
chronic heart failure due to ischaemic heart disease and dilated cardiomyopathy
(Levine et el-. 1990; Swedberg et ai·, 1990; Matsumori et eï-. 1994; Torre-Amione et
et.. 1996). Cardiac myocyte hypertrophy is a principle feature of such cardiac
diseases (Gilbert and Bristow, 1994; Beltrami et el-. 1994), and TNFa is an important
factor that may induce hypertrophy.
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Figure 2.3.2.1: Model for an adaptive and maladaptive roles of TNFc (Modified from
Sack et et-. 2000)
The direct effect of TNFu on cardiac cells has been demonstrated in cultured
myocytes (Long et et.. 1991; Yokoyama et a/., 1997). The phenotypic alterations are
thought to be an adaptive response in order to maintain normal contractility and
homeostasis in response to an increased workload. A simple passive stretch of cat
papillary muscle induced the expression of TNF mRNA and it has been suggested
that physiologically relevant concentrations of TNFu provoke hypertrophic response
by increasing the synthesis of both structural and contractile protein in adult feline
cardiocytes (Kapadia et a/·, 1997; Yokoyama et a/., 1997).
TNFu exerts cytotoxic activity on some types of tumor cells, in part via the generation
of reactive oxygen intermediates (ROls) (Matthews et el-. 1987; Wong et a/., 1989;
Goossens et el-. 1995) and JNK activation in cardiac myocytes. ROls are involved in
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many biological processes as they are involved in the defense against micro-
organisms, and they can cause host cell injury directly. ROls also take part in
regulating the expression of various genes and cell growth (Rao and Berk, 1992;
Marui et aL, 1993). ROls specifically stimulate DNA synthesis and the expression of
proto-oncogenes such as c-myc and c-fos in vascular smooth muscle (Rao and Berk,
1992). Nakamura and colleagues (1998) demonstrated that antioxidants can inhibit
TNFa induced cardiac hypertrophy in cultured neonatal rat myocytes. However, the
exact signaling pathways involved in Ral induced cardiac hypertrophy need further
investigation (Nakamura et eï. 1998).
TNFa binds to its cognate homotrimeric receptor, forming multimolecular signal
transduction complexes, which can rapidly activate several divergent downstream
signaling pathways (Sack et et-, 2000). TNF-R1 and TNF-R2 are co-expressed on
most cell types, but signaling from TNF-R1 is thought to be more important of the two
receptor types in the heart, since transfection experiments, receptor specific
antibodies, and experiments with gene-knock-out mice have shown that TNF-R1 is
the dominant signaling receptor (Tartaglia and Goeddel, 1992; Vandenabeele et et-.
1995). TNF-R1 can signal apoptosis and activate the transcription factor nuclear
factor-kappa B (NF-KB), while TNF-R2 can directly signal certain activities in
lymphocytes such as NF-KB activation and help deliver TNFa to TNF-R1 (Tartaglia et
et-, 1993b). The inflammatory response, but not the hypertrophic response, can be
attenuated by genetic attenuation of the TNF-R1 signaling pathway (Bounoutas et aI.,
1998).
The TNF-R2 signaling complex involves proteins of the intracellular domain required
for signaling, and these are called TRAF-1 and TRAF-2 (Rothe et aI., 1994, Rothe et
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a/., 1995). TRAF-1 and TRAF-2 can form both homodimers and heterodimers
through their TRAF domains, but only TRAF-2 interacts directly with TNF-R2 (Rothe
et el- 1994). TNF-R1 contains a death domain in its intracellular domains that signals
apoptosis and NF-KB activation (Tartaglia et el-. 1993a; Hsu et a/·, 1995; Hsu et a/·,
1996b), and these are termed as TNF receptor-associated death domain (TRADD).
Upon TNFa binding to its receptors, TNF-R2 forms a complex with TRAF2, activating
both NFKB-dependent and independent transcriptional events implicated in the
cytoprotective genes involved in cellular growth, survival and proliferation (Natoli et
et-. 1998). The cytoprotective pathway includes the hypertrophic growth programme
downstream of PKC (Baines et al., 1999), NFKB, stress activated protein kinases
(SAPK) and JNK (Baines et al., 1999).
Receptor interacting protein (RIP) is a cytoplasmic serine/threonine protein kinase
that contains a C-terminal death domain. It was originally described as a Fas-
interacting protein (Stanger et el-, 1995), however it has been suggested that it does
not interact with Fas in mammalian cells, but rather TRADD interacts strongly with
RIP and recruits RIP to the TNF-R1 complex (Hsu et eï-. 1996a) (Figure 2.3.3.1).
2.3.4 TNFg, and the sphingomyelin pathway
Sphingomyelin is a phospholipid found in the plasma membrane of mammalian cells.
Signaling through the sphingomyelin pathway is associated with generation of
ceramide, which acts as a second messenger in activating a variety of cellular
functions. Ceramide belongs to the group of sphingosine based lipid second
messenger molecules that are critically involved in the regulation of signal
transduction of diverse cell surface membrane receptors (Kronke, 1999). Following
membrane receptor triggering by TNFa, neutral and acid isoforms of
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sphingomyelinases are rapidly activated, generating ceramide through sphingomyelin
hydrolysis (Kronke, 1999). Increased intracellular ceramide concentrations have been
implicated in the induction of apoptosis in a number of cell types (Cifone et et-, 1994;
Haimovitz-Friedman et eï-. 1994; Jayadev et el-. 1995).
Ceramide is produced primarily by the hydrolysis of sphingomyelin through
sphingomyelinase (SMase), or from palmitoyl CoA and serine through de novo
synthesis. Ceramide, once generated, can be metabolized or converted to other
molecules by various enzymes such as ceramidase, glucosylceramidase synthase,
eeramide kinase, and sphingomyelin synthase (Luberto and Hannun, 1999; Hannun
and Luberto, 2000).
With respect to the alteration of intracellular ceramide levels in response to cytokines,
it has been demonstrated that this alteration mainly resulted from the two
modulations of two isoforms of SMase, the neutral (N-) and acidic (A-) SMase, and
ceramidase in a variety of mammalian tissues and cells.
A- and N- SMase were found to be stimulated by TNFa, IL-1 p, and interferon-c. and
ceramidase can be activated or inhibited by these cytokines (Kim et et-, 1991;
Mathias et al·, 1993; Kolesnick and Galde, 1994; Hannun, 1994; Coroneos et el-.
1995; Nikolova-Karakashian et al., 1997). Zhang and colleagues (2001)
demonstrated that N-SMase, A-SMase and ceramidase are present in the
myocardium of rats. They concluded that increases in tissue ceramide levels during
ischaemia/reperfusion are not associated with enhanced SMase activity, but rather
with inhibition of ceramidase, which is contrary to the findings of other studies
(Hernandez et el-. 2000), where hypoxia and reoxygenation in cultured rat myocytes
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was reported to induce N-SMase and then the accumulation of ceramide. Reasons
for these discrepancies are unknown (Zhang et el-. 2001) (Figure 2.3.3.1).
2.3.5 Other Cytokine signal transduction pathways in cardiac hypertrophy
Janus-associated kinases (JAKs) were first identified as protein tyrosine kinases
associated with cytokine receptors that regulate signal transduction of these
receptors (Ihle, 1995). The JAK family consists of Jak1, Jak2, Jak3 and Tyk2. They
have a molecular mass ranging from 120 to 130 kDa (Ihie, 1995). Signal transducers
and activators of transcription (STATs) are latent transcription factors located in the
cytoplasm, which become activated by phosphorylation of a tyrosine residue.
They are both named after their dual functions in signal transduction in the cytoplasm
and activation of transcription in the nucleus (Schindler and Darnell, 1995; Horvath
and Darnell, 1997). Binding of ligand to their cytokine receptors leads to
phosphorylation and activation of the receptor-JAK complex with subsequent
recruitment and activation of STATs by phosphorylation. The phosphorylated STATs
dimerize, migrate into the nucleus and bind response elements in the promoters of
target genes to stimulate gene transcription (Ihle, 1995; Schindler and Darnell, 1995).
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Figure 2.3.3.1 Signalling pathways of TNFRs after activation by TNF c: The figure
shows the recruitment of various docking proteins to TNF-R1 and TNF-R2. These
include: tumor receptor associated death domain (TRADO), receptor interacting
protein (RIP), TNF receptor associated factor 2 (TRAF2), and Fas-associated death
domain protein (FADO), alternate name, MORT1, (mediator of receptor induced
toxicity). Recruitment of these docking proteins is coupled to the activation of
numerous signalling pathways leading to inflammation, apoptosis or multiple gene
activation. The phospholipase A2 (PLA2) include: cyclooxygenase (COX);
prostaglandines (PGs), and thromboxanes (TXs). The phospholipase C (PLC)
pathway includes diacylglycerole (DAG), sphingomyelinase (SMase) and protein
kinase C (PKC). The mitogen activated kinase (MAPK) include NFKB inducing kinase
(NFKB), the NFKB transcription factor subtypes-p-50 and p65 and the NFKB cytosolic
anchoring protein complex or inhibitory protein IKB. The TRAF2 or PKC activated
pathway is represented by Janus N-terminal kinase/stress activated protein kinase
(JNKlSAPK) with activation of genes via activation protein-1 (AP-1). (Adapted from
Sack et et-. 2000).
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In case of receptor complexes sharing the glycoprotein 130 (gp130), such as
members of the interleukin (IL)-6 family (cardiotrophin-1) (Latehman, 2000), signal
transduction is triggered by the formation of dimers of gp130 (Kishimoto et al., 1994).
Activation of STATs also occurs through the receptor families other than the cytokine
receptor family such as tyrosine kinase receptors (Takahashi et al., 1999) and G-
protein-coupled receptors (Bhat et sl.. 1994; McWhinney et el-. 1997; Mascareno et
el-, 1998). The JAK/STAT pathway was activated in rat hearts with pressure
overload-induced cardiac hypertrophy and this is mediated by gp130 (Pan et el-,
1998).
Ligand binding to the gp130 and low affinity leukemia inhibitor factor receptor (LIFR)
complex results in phosphorylation of Janus kinase (Jak) signaling factors, which in
turn phosporylates gp130, generating a docking site for SH2 domain-containing
proteins (Narazaki et eï-. 1994). The MAPK pathway is activated through Ras by
activated gp130 (Nakafuku et et-. 1992; Kumar et et-. 1994; Kunisada et el-, 1996)
(Figure 2.3.4.1).
2.4 TNFa and Obesity
TNFa is over-expressed in adipose tissue of obese insulin-resistant rodents and
humans, and TNFa antibody administration has been shown to counteract insulin
resistance in the fat and muscle of obese Zucker rats (Hotamisligil et el-. 1994).
These data would suggest a role for TNFa in the pathophysiology of insulin
resistance.
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Figure 2.3.4.1: gp130 and Jak/STAT signalling pathway. Once gp130 is activated by
LlF, cardiotrophin or other cytokines of the IL-6 cytokine family, this receptor interacts
with Janus kinase 1 causing its activation, which in turn leads to STAT
phosphorylation promoting dimerization and nuclear entry. gp130 also promotes the
activation of phosphatidylinositol 3-kinase (PI3K, Ras and mitogen-activated protein
kinase kinase kinases (MEKK). (Adapted from Molkentin and Dorn, 2001)
Although several studies have demonstrated an over-expression of TNF a in adipose
tissue and elevated plasma concentrations of the two soluble TNF receptors in obese
animals (Hotamisligil et al., 1995; Kern et el.. 1995; Hube et al·, 1997; Hauner et al·,
1998), it still remains unclear whether an increased adipose tissue production of
TNFa is reflected by elevated circulating plasma TNFa levels. TNF a activity
represents the summation of TNFa synthesis, secretion and the amount of soluble
inhibitors present and several studies have only measured membrane TNF a receptor
density or mRNA levels (Hauner et al., 1998).
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In the past it was believed that the effects of TNFa in vivo was confined to activated
macrophages and lymphocytes (Beutler and Cerami, 1988). However further
research provided strong evidence that TNFa is found in adipose tissue and that
levels increase in obese and insulin-resistant rodents (Hotamisligil et el-, 1993).
Administration of exogenous TNFa induced increased circulating TNFa that has
marked effects on lipid metabolism (Hotamisligil et al., 1995). Increases in
triglycerides, attributed to the induction of lipolysis and stimulation of hepatic
lipogenesis have been observed (Beutler and Cerami, 1988; Grunfeld and Feingold,
1991; Spiegelman and Hotamisligil, 1993).
TNFa has multiple actions in adipose tissue, which include increased insulin
resistance associated with the defects in insulin-stimulated glucose disposal,
decreased activity of lipoprotein lipase and increased hormone-sensitive lipase,
preventing lipid accumulation (Kern et al., 1995). TNFa may be a local regulator of fat
cell size, hence the overproduction of TNFa in adipocytes of obese animals could
represent a form of adipostat designed to limit the adipocyte size enlargement
(Hotamisligil et al., 1995).
When a soluble TNFa binding protein was infused into fa/fa rats, which have high
levels of adipose tissue TNFa, there was a 2-3 fold increase in insulin stimulated
glucose uptake, along with improved insulin receptor autophosphorylation in both
adipose tissue and muscle (Hotamisligil et eï-. 1993; Hotamisligil et el-. 1994). TNFa
neutralization however did not affect the insulin-mediated suppression of hepatic
glucose output, and it is not clear whether the peripheral insulin resistance of the
fa/fa rats was partially or completely normalized, since no parallel lean rats were
investigated (Hotamisligil et el-. 1993). These findings were supported by studies on
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Zucker fa/fa rats in vivo, where reduced insulin levels, free fatty acid levels and partial
improvement in peripheral insulin sensitivity were observed (Cheung et et-. 1998). In
contrast, neutralization of circulating TNFa with anti-TN Fa antibodies did not affect
hyperlipidemia in another study involving Zucker fa/fa rats (Lopez-Soriano et ai.,
1997). Hence the down-regulation of any component that regulates the metabolic
effects of insulin represents a plausible mechanism for how TNFa may mediate
insulin resistance. However controversy surrounds the role of adipose tissue-derived
TNF (AT-TNF) in insulin resistance.
In in vitro systems such as isolated adipocytes or cultured 3T3-Li adipocytes, TNFa
can potentially suppress the expression of genes encoding proteins that normally
regulate fatty acid uptake or lipogenesis. These include acetyl CoA carboxylase, LPL
and glycerophosphate dehydrogenase (Zhang et eï-. 1996). The cytokine has also
been shown to inhibit preadipocyte differentiation and it might also induce in vitro
differentiation of 3T3-Li adipocytes (Zhang et el-. 1996). These negative effects on
adipocyte differentiation correlate with the suppression of other adipocyte genes,
such as those encoding adipsin and the insulin-responsive glucose transporter
(GLUT 4) (Stephens and Pekala, 1991; Szalkowski et el-. 1995; Zhang et et-. 1996).
There also seems to be a discrepancy between the role of AT-TNF on the insulin
action when studied in vitro or in vivo (Morin et el-. 1998). AT-TNF activity was
increased in 14 month- in comparison with 3-month-old Fisher 344 rats and in the
retroperitoneal fat pad only the activity of TNFa was weakly related to fasting plasma
insulin (Morin et eï-. 1997). However, the TNFa activity was strongly correlated with
cell size in both the epididymal and the retroperitoneal pads, and this cell size
increases with age (Morin et el-. 1998).
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Studies on the role of TNFa originating from adipose tissue are therefore
controversial and do not confirm or refute its importance in the development of insulin
resistance or other pathological conditions. To our knowledge nothing is known about
the effect of AT-TN Fa on the cardiovascular system.
2.5 TNFa and iNOS
The wide range of TNFa activities and effects are explained by the presence of TNF-
receptors on almost all nucleated cell types. The idea that the heart itself is a target
for TNF is supported by the evidence, that circulating levels of TNFa are high in CHF
patients and myocardial TNF-Rs are low (Torre-Amione et et-. 1996). It has also been
reported that TNFa is responsible for the expression of the cytokine-induced high
output isoform of nitric oxide synthase (NOS), iNOS or NOS2 (Goldhaber et el-
1996). The expression of cationic amino acid transporters necessary for the uptake of
the NO-precursor L-arginine and enzymes required for the production of
tetrahydrobiopterin, a cofactor essential for iNOS activation, are also induced by
TNFa (Latini et el-. 1994; Packer, 1995; Torre-Amione et et-, 1996).
The three isoforms of NOS originally identified in the brain (nNOS), macrophages
(iNOS) and endothelial cells (eNOS) share 50% to 60% homology of their amino acid
sequence and are encoded by three different genes (NOS 1, NOS 2, NOS 3) (Bredt
et el-. 1991; Lyons et sl-. 1992; Lamas et el-. 1992; Nishida et el-. 1992). All three
isoforms combine two functionally complementary portions, a carboxyl-terminal
reductase domain homologous to cytochrome P450 reductase and an amino-terminal
oxygenase domain containing binding sites for heme, L-arginine, and
tetrahydrobiopterin (THB4), the two portions being connected by a calmodulin-
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binding domain in the middle. On activation, the three isoforms presumably function
as homodimers. Within each monomer, electrons provided by NADPH are transferred
from the flavins (FAD or FMN) in the carboxyl-terminal portion of the molecule to
heme iron, which is activated to bind O2 and in the presence of the substrate L-
arginine, to catalyze the synthesis of NO and L-citrulline.
iNOS generates a prolonged release of large amounts of NO which may be cytotoxic
and/or inhibit myocyte contractility (Vejstrup et et-. 1998). The resulting increase in
NO production from cardiac myocytes and other cell types further impairs ventricular
function by increasing intracellular cGMP or by altering specific sarcolemmal ion
channels (Ungureanu-Longrois et el-, 1995; Kelly et et-. 1996; Campbell et el-, 1996;
Gross et et-. 1996; Kelly and Smith, 1997).
TNFa induced desensitization of myofilaments to intracellular calcium is possibly
mediated by NO. It has been demonstrated that TNF-induced, sphingosine-mediated
disruption of calcium induced calcium release occurs early and NO mediates TNFa
induced desensitization of myofilaments to calcium (Gurevitch et et-. 1996; Vila-
Petroff et ai., 1999) (Figure 2.5.1). Depressed myocardial contractile responses to
Ca2+ have also been reported in pathological settings such as myocardial infarction
and allograft rejection, where there is abundant expression of iNOS in macraphages
infiltrating the myocardium (Yang et ai., 1994; Worrall et ai·, 1995; Suzuki et ai·,
1996).
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2.5.1 cGMP-dependent pathway
Studies have suggested that NO is capable of inducing either a positive or negative
inotropic response in cardiac myocytes. The cGMP-activated pathway is involved in
the molecular mechanisms by which NO influences myocardial performance (Ignarro,
1990). NO and cGMP can decrease the cardiac myocyte L-type calcium current and
contraction through activation of cGMP-stimulated cAMP phosphodiesterase
(Balligand and Cannon, 1997). There is therefore a decrease in intracellular cAMP
levels, initiating a lowered cAMP dependent protein kinase activity (PKA), which in
turn alters the phosphorylated state of several target proteins. These include the a-
subunit of the L-type calcium channel (Mery et el-. 1993; Han et aI·, 1994 Han et el-,
1995; Han et al., 1996). The down-regulation of calcium current is induced by the
phosphorylation of the channel or poshosphorylation of an intermediate protein,
namely cAMP phosphodiesterase (POE), opposing the effect of PKA (Mery et el-,
1993). In addition cGMP dependent protein kinase (PKG) also decreases
myofilament sensitivity to calcium, thereby promoting relaxation (Balligand and
Cannon, 1997). On the other hand it has been suggested that this inhibitory effect of
PKG may be due to the direct phosphorylation of the Ca2+ channel or an associated
regulatory protein. There may be a balance between activities of PKA and PKG in
regulating the Ca2+ channels at two separate sites (Sumii and Sperelakis, 1995).
A recent study has also suggested that NO is capable of inducing either a positive or
negative inotropic response in cardiac myocytes depending on the concentration of
NO donor used, in the presence or absence of specific inhibitors of soluble guanylyl
cyclase (sGC), PKG and PKA. Vila-Petroff and colleagues (1999) demonstrated that
although the decrease in contractile response observed at higher levels of NO can be
attributed mainly to a cGMP-dependent reduction in myofilament responsiveness to
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Ca2+, the enhanced contractile response at lower NO levels is due to increased
intracellular cAMP levels. These levels are possibly mediated in part through a novel
NO-dependent, cGMP independent activation of adenylyl cyclase (AC) (Vila-Petroff
et et-. 1999). It therefore seems that the NO levels being generated may be critical,
and we know that iNOS generates high levels of NO. We therefore expect that these
high levels would reduce the contractile function of the heart.
2.5.2 cGMP-independent pathway
Some or all of the cGMP-dependent pathways coexist in some cells (Wang and
Lipsius, 1995; Han et el-. 1996; Kojda et el-, 1996), and the predominance of anyone
to produce the observed effect may vary according to the species used or the region
of the heart, as well as the stimulus and the experimental conditions used (Balligand
and Cannon, 1997). However, NO or its redox-related derivatives may also regulate
Ca2+ channel function and cardiac contraction through mechanisms independent
from cGMP.
NO produces oxidants such as peroxynitrite and it has been demonstrated that
peroxynitrite inhibits enzymes involved in the citric acid cycle, such as the interaction
between cis-aconitase and iron-sulfur clusters (Beckman and Koppenol, 1996;
Hausladen and Fridovich, 1994). Reduced oxygen consumption in muscle slices has
been reported where NO has presumably inhibited mitochondrial electron transfer, an
effect that was reproduced in neonatal rat ventricular myocytes treated with IL-1 p
(MacDonald and Moss, 1993; Shen et el-. 1994; Shen et et-. 1995; Oddis and Finkel,
1995). It is suggested that this effect could involve the inactivation of the heme
moiety of cytochrome c oxidase by NO (Torres et el-. 1995) (Figure 2.5.1).
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Figure 2.5.1: Simplified signalling pathway for the action of NO in cardiac myocytes.
These include: Tumor necrosis factor alpha (TNFa)' inducible nitric oxide synthase
(iNOS), soluble guanylyl cyclase (sGC), phosphodiesterase (POE), and cAMP
dependent protein kinase (PKA). (Modified from Balligand and Cannon, 1997;
Meldrum, 1998).
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2.5.3 TNFa, iNOS and apoptosis
Programmed cell death (apoptosis) is a process by which cells undergo inducible
non-necrotic cellular suicide. In contrast with necrotic cell death, programmed cell
death is dependent on the de novo synthesis of proteins that initiate a cellular suicide
program in response to specific stimuli (Steller, 1995; Thompson, 1995; Vaux and
Strausser, 1996). For most cells of hematopoeitic lineage, apoptosis is a constitutive
process but can also be induced by noxious stimuli (Ayala et el-, 1996). It has
become apparent that apoptosis contributes to the pathophysiology of
neurodegenerative diseases, autoimumune diseases, acquired immunodeficiency
syndrome, cancer and a number of myocardial diseases (Steller, 1995; Thompson,
1995; Vaux and Strausser, 1996).
Cardiac myocyte apoptosis occurs in chronic heart failure, ischaemia,
arrhythmogenic right ventricular dysplasia, myocarditis and sudden cardiac death
(Gottlieb et et- 1994; Packer, 1995; Krown et el-, 1996; Olivetti et el-, 1997).
Apoptosis is characterized by cell death, but the cell membrane integrity is
maintained. Therefore apoptotic cardiac myocytes do not release creatine kinase and
retain their ability to exclude dyes such as trypan blue (Kajstura et et-. 1996). It has
been proposed that cardiac myocytes also retain their ability to contract in response
to calcium inophores (Krown et el-. 1996). By contrast, necrosis is associated with a
high influx of calcium where myocytes are maximally contracted and unable to
contract further in response to a calcium inophore (Meldrum et et-. 1996).
Studies have shown that chronic TNFa production in the heart may lead to
permanent functional impairment and apoptosis via NO-dependent and independent
pathways (Szaboles et eï-. 1996; Haywood et et-. 1996; Natoli et ei-. 1997). When
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TNFa binds to its receptor, a number of TNF receptor-associated proteins assemble
and associate to the cytoplasmic end of TNF receptors. These include TRADD, which
recruits FADD (also known as MORT1) protein and TRAF2. TRAF2 interacts with
TRADD and an N-terminal ring finger required for signaling the activation of NF-KB
and JNKlSAPK (Rothe et a/., 1995; Liu et et-. 1996; Natoli et el.. 1997). Activation of
TRADD is also associated with the recruitment and activation of apoptotic proteases
with subsequent progression to programmed cell death (Sack et el-, 2000) (Figure
2.3.3.1 ).
TNFa also induces iNOS release and NO induced cardiac myocytes apoptosis may
possibly be mediated by a cGMP independent mechanism, namely via the generation
of oxygen-derived free radicals such as peroxynitrite (Ing et el-. 1999). However, it
remains unclear as to how and to what extent NO itself, or peroxynitrite, contributes
to iNOS-dependent cell death in cardiac myocytes (Arstall et el-. 1999).
Several studies have shown that NO donors can trigger apoptosis in macrophages,
vascular smooth muscle cells and cardiac myocytes (Albina et a/., 1993; Cui et et-.
1994; Shimaoka et el-. 1995; Pinsky et a/·, 1995; Nishio et a/·, 1996). /n vivo studies
have also demonstrated that apoptosis of macrophages and cardiac myocytes occurs
in parallel with iNOS induction in experimental models of cardiac allograft rejection
and myocardial infarction (Szaboles et el-. 1996; Suzuki et et-. 1996). NO produced
by iNOS may diminish cardiac function as a result of cell death, which is possibly
triggered by apoptosis (Beckman and Koppenol, 1996; Szaboles et el-. 1996).
There is evidence that programmed cell death of myocytes occur in the
decompensated human heart, although there is an enhanced expression of BcI-2, the
proto-oncogene, which protects cells from apoptosis (Gravanis et eï. 1994; Szaboles
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et a/·, 1996; Olivetti et eï.. 1997). It has also been demonstrated that some cytokines
(IL-1 pand IFNy) induce apoptosis associated with an increased Bax relative to BcI-2
expression in isolated neonatal rat ventricular myocytes (Ing et ei-, 1999; Arstall et
eï, 1999).
2.6 Ischaemia/reperfusion injury
Ischaemia by definition exists whenever the flow of arterial blood through coronary
blood vessels is reduced to a volume below that required by the myocardium for
normal function. The myocardium is therefore deprived of oxygen, and a shift from
aerobic to anaerobic metabolism occurs (Jennings 1970, Jennings and Yellon 1992).
The severe and sustained reduction in blood flow to the myocardium reduces the
oxidative phosphorylation leading to failure to resynthesize energy-rich phosphates
such as ATP and creatine phosphate. With this profound reduction in energy stores
active tension generation is decreased. As a result ion homeostasis is lost, causing a
leakage of K+ into the extracellular environment and Ca2+ into the cytoplasm. These
changes contribute to the electrical instability in the cells and a failure of relaxation
(Maxwell and Lip, 1996).
Ischaemia induced alterations in the myocardium strictly depend on the duration and
severity of ischaemia. Prolonged myocardial ischaemia inevitably results in
myocardial death (Buerke et et.. 1999). Acute myocardial ischaemia results in an
intense inflammatory reaction (Engler et el-. 1986; Jones et sl-. 1999).
Reperfusion is defined as the full restoration of blood flow to the ischaemic area.
However experimental models have demonstrated that reperfusion can inflict
microvascular and myocyte damage, which compromises return of normal coronary
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perfusion and cardiac function (Ryan et el-. 1990; Knabb et aI., 1987). The resultant
reperfusion injury was originally defined as the metabolic, functional and structural
consequence of restoring coronary artery flow that can be avoided or even reversed
by the modification of the conditions of reperfusion (Rosenkranz and Buckberg,
1983). Yet despite the risk of exacerbating the ischaemie injury, it is an absolute
prerequisite for the survival of ischaemic tissue (Hearse, 1977; Braunwald and
Kloner, 1985; Becker and Ambrosio, 1987; Opie, 1989).
Myocardial ischaemia/reperfusion injury is exacerbated by cytosolic Ca2+ overload
(Du Toit and Opie, 1992). Ischaemia/reperfusion also generates high levels of free
radicals composed of both reactive oxygen intermediates and NO (Kilgore and
Lucchesi, 1993). When these are generated in sufficient concentrations, free radicals
directly injure the myocardium and may even cause cell death. Free radicals also
activate redox-sensitive transcription factors, including NF-KB, and trigger the
expression of IL-1~, TNFa and other proinflammatory mediators (Mercurio et aI.,
1997; Mercurio and Manning, 1999; Bowie and O'Neill, 2000; Bonizzi et el-. 2000).
Although high levels of NO may contribute to certain cardiovascular disorders, there
is experimental evidence to suggest that low levels of NO may be essential for
normal cardiac homeostasis. It plays a key role in normal myocardial physiology, and
it is suggested that at low physiological concentrations NO may protect myocytes
from deleterious stimuli such as mechanical stress, ischaemia and norepinephrine
(Sharma et el-. 2000). The mechanisms involved in NO protection during mechanical
stress and norepinephrine administration remain unclear (Sharma et eï-. 2000). Du
Toit and colleagues (1998) demonstrated that stimulation of the NO-cGMP pathway
during severe ischaemia with NO-donors protected the heart against ischaemic and
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reperfusion injury, possibly by decreasing cytosolic Ca2+ overload during ischaemia
and reperfusion.
On the other hand studies have also shown that a NO-inhibitor L-NAME reduces
infarct size (Patel et el-. 1993; Woolfson et et-. 1995). The mechanisms by which NO
results in these contrasting effects may involve decreases and increases in oxidative
stress, respectively (Sawyer and Colucci, 1998). Curtis and Pabla (1997) suggest
that the protective effects of some NOS inhibitors may occur by NO-independent
mechanisms.
2.6.1 TNFg and ischaemia/reperfusion injury
There are three main theories as to why there are high levels of TNFa in CHF. One
hypothesis is that the heart is the main source of this cytokine, since it has been
shown that the failing myocardium is capable of producing TNFa (Torre-Amione et
et-. 1996). /n vivo studies have also reported that haemodynamic pressure overload
is capable of stimulating TNFa mRNA synthesis (Kapadia et el-. 1997). The second
hypothesis is that the bowel wall oedema, which occurs in CHF is responsible for
bacterial translocation with subsequent endotoxin release and immune activation
(Anker et el-. 1997). The third hypothesis is that hypoxia may be a stimulus for
increased TNFa production in CHF patients (Hasper et el-. 1998).
Although little is known about the mechanisms of ischaemia and reperfusion induced
myocardial TNFa production (Gurevitch et et-. 1996), it has been established, that
reperfusion of the ischaemic myocardium imposes an oxidant burden on the
myocardium in which the reduction product of molecular oxygen and hydrogen
peroxide contribute to myocardial injury (Brown et a/., 1988). Hydrogen peroxide
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induces activation of p38 MAP kinase, and this may also contribute to the ischaemia-
reperfusion induced TNFa-production (Guyton et el-, 1996; Huot et al., 1997).
Oxidant stress may also activate NFKB, involved in the sequence of
ischaemia/reperfusion induced TNFa production.
In most cells, NFKB exists in a latent state, unable to induce TNFa production
(Mallin in et al., 1997). While in this latent state, NFKB is bound to its inhibitory
proteins, called Inhibitory KB (lKB). After activation by ischaemia-reperfusion,
phosphorylation of IKB results in the disruption of the NFKB-IKB complex and the
degradation of IKB (Li and Sedivy, 1993; Trede et eï. 1995; Sweet and Hume, 1996).
Liberated NFKB then translocates from the cytoplasm to the nucleus, where it docks
to DNA at one of four NFKB sites (TNF promoter region) (Shakov et el-, 1990).
Evidence shows that NFKB is activated directly either by phosphorylation of IKB or by
oxidant stress, after which it translocates to the nucleus to activate TNF gene
transcription (Meldrum, 1998) (Figure 2.6.1.1).
The association of elevated inflammatory cytokine levels with a poor prognosis in
heart failure, together with their known adverse effects on myocardial structure and
function, suggests that cytokines are likely to be detrimental in this condition
(Suffredini et et-. 1989; Torre-Amione et al·, 1995; Torre-Amione et el-. 1996). Studies
have suggested that the increased levels of TNFa following ischaemia/reperfusion
contribute to infarct development, and the inflammatory response causes a degree of
myocyte loss (Hansen, 1995; Gurevitch et el-. 1997). However it has been
established that the primary function of the proinflammatory response is to protect the
body from infections and other stresses to which it is exposed. It is only when the
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inflammatory response becomes overactive or is inappropriately stimulated, that it
begins to have harmful effects.
It has been proposed that cytokines expressed within the myocardium in response to
environmental injury, may be important initiating and integrating homeostatic
responses within the heart (Mann, 1996; Sharma et el-. 2000). Therefore it is
suggested that the short-term expression of inflammatory cytokines may provide the
myocardium with an adaptive response to stress, whereas the long-term expression
of these molecules may be maladaptive by producing cardiac decompensation (Sack
et al·, 2000).
Nelson and colleagues (1995) demonstrated that pretreatment of rabbits with
intravenous TNFa 24 hours before ischaemia and reperfusion resulted in improved
cardiac contractile functional recovery. Sack and colleagues (2000) confirmed these
results, but induced milder ischaemia with less production of TNFa, allowing a
positive response to the added low concentrations of TNFa in the myocardium. It was
therefore suggested that the known production of TNFa by the myocardium in
response to an ischaemic/reperfusion insult, may in fact be an endogenous pathway
activated by the heart to induce short-term intrinsic cardioprotection against
subsequent ischaemia/reperfusion injury. Conversely, Nutt and colleagues (1998)
demonstrated that cardiac contractile function was markedly attenuated at high
concentrations of TNFa infusion. It remains controversial whether TNFa's role in
inducing an acute reduction of contractility is adaptive and confers cardioprotection or
whether it is maladaptive leading to long-term myocardial dysfunction during
ischaemia and reperfusion. However, to our kowledge, the effects of TNFa from
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other sources such as AT-TN Fa during ischaemia and reperfusion have not been
documented.
ISCHAEMIA
+
Oxidant stress
+
Hydrogen peroxide
TNFa
,
,
\ ....
transcription
DNA
Figure 2.6.1.1: TNFa synthesis in myocytes. Ischaemia/reperfusion, oxidant stress,
and hydrogen peroxide directly activate p38 MAPK and NFKB, to induce TNF a
production. Once transcription to pro-TNF a occurs in the cytosol, myristoylation
permits membrane insertion, where pro-TNF remains until it is cleaved to its mature
form by TNF a -converting enzyme (TACE) (modified from Meldrum, 1998).
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Chapter 3
MATERIALS AND METHODS
3.1 Experimental Model
3.1.1 Rat Diet
Human obesity is often associated with a Western lifestyle, which includes the
availability of highly palatable foods. A model of diet induced obesity (OIO) in the rat
(pickavance et el-, 1999) was therefore chosen for this study. The OIO rat model is
characterized by hyperphagia, increased thermogenesis, hyperleptinaemia and mild
insulin resistance (MCormack et eï-. 1989; Wilding et sl-. 1992; Widdowson et et.
1997).
The diet used contained a slightly elevated carbohydrate content, and for the
purpose of this study was referred to as a high caloric diet. The diet provided 65% of
the energy in the form of carbohydrates, 19% as protein and 16% as fat. This diet
was designed to induce hyperphagia, without employing major changes in macro-
nutrient composition, when compared with normal rat chow. This model was found
reliable for inducing weight gain and mild insulin resistance (Wilding et el-. 1992;
Widdowson et aI·, 1997; Pickavance et el-. 1999). The control rats were fed a rodent
pellet chow (standard rat chow), which provided 60% of energy in the form of
carbohydrates, 30% as protein and 10% as fat.
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3.2 Indices for Identifying Cardiac Hypertrophy
3.2.1 Heart weight to body weight ratio
The use of the heart weight to body weight ratio to identify cardiac hypertrophy was
established by Walter and Addis in 1939, and has subsequently been used as an
index of cardiac hypertrophy in other studies (Villa et el-. 1998; Wambolt et el-, 2000).
3.2.2 Heart weight to tibia length ratio
This parameter offers another method of identifying cardiac hypertrophy and is one
that is physiologically related to the metabolic demands placed on the heart by the
body and reflects relative lean body size throughout life. The tibia length in rats
change minimally beyond maturity even though the epiphysis does not close. The
tibia growth curve therefore appears to be independent of the presence or absence
of gross pathological lesions appearing during the lifetime of the rat and seems to be
independent of changes in the body weight (Berg and Harmison, 1958). Yin and
colleagues (1982) only managed to apply the tibia length to heart weight ratio as a
parameter for cardiac hypertrophy in older (fully grown) rats. This method may
therefore be used as an alternative parameter for quantifying hypertrophy in fully
grown rats.
3.3 Animals
Male Sprague-Dawley rats were weaned at 3 weeks and put on a high caloric diet for
12 weeks. The control animals had free access to standard rat chow and water, while
those on the high caloric diet had unlimited access to food containing 33% chow,
33% condensed milk, 7% sucrose and 27% water, and drinking water. They were
maintained in animal quarters at a constant temperature (22°C) and humidity (40%)
with a 12-hour day/night cycle. The South African Medical Research Council's guide
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for the humane use of laboratory animals was followed throughout.
3.4 Measurements made during the study
3.4.1 Food consumption
Food intake was measured daily for both the groups and expressed in grams of food
consumed per week (grams/week).
3.4.2 Body weight gain
Animals were weighed weekly and their weights documented. Their respective body
weight gain is expressed in both weight gain/week and total weight gain over 12
weeks.
3.4.3 Heart weight
At the end of the perfusion protocol, the hearts were carefully removed from the
perfusion apparatus, dried off and incisions were made through the atria to the
ventricles. Hearts where then blotted on paper towel to remove excess water and
perfusion buffer. Heart weights are expressed in milligrams. The heart weight to body
weight ratio was determined and used as an index of cardiac hypertrophy. The tibia
length was measured in centimeters using a vernier. These lengths were also
expressed relative to heart weight and used as an index of cardiac hypertrophy.
3.4.4 Glucose levels
Blood glucose levels were measured in non-fasted animals with an Accutrend ®
blood glucose analyser and Accutrend" glucose test strips (Boehringer Mannheim,
Germany).
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3.4.5 Insulin
An Insulin solid phase 1251 radioimmunoassay (COAT-A-COUNT®, Diagnostic
Products Corporation, Los Angeles, CA) was used to measure insulin in the serum
3.4.6 Lipid profiles
Lipid profiles were determined by spectrophotometric analysis (Technicon RA 1000
Auto analyser) using Technicon assay reagents, measuring in mmoiii plasma
Cholesterol, HDL cholesterol and plasma TAG. LDL cholesterol quantification
requires a more specialized assay procedure (beta-quantification). We therefore
chose not to measure LDL cholesterol in this study.
3.5 Heart perfusions
3.5.1 The isolated Rat Heart Model
The system consists of two parts; the Langendorff perfusion side, used to perfuse the
heart in a retrograde fashion, and the working heart side used to perfuse the heart in
the working heart mode. The retrograde Langendorff perfusion apparatus was used
to allow the hearts to stabilize at the beginning of the experiment and during
reperfusion. The apparatus was first described by Langendorff in 1895, and later
modified by Neely and co-workers (1967). In order to measure mechanical function of
the heart, the working heart model was used.
3.5.2 Perfusion Solution
The perfusion solution was a crystalloid Krebs- Henseleit buffer, containing in mM:
NaCI 118,46; NaHC0324,995; KCI 4,748; KH2P04 1,185; MgS04.7H20 1,19 and
CaCI2.2H20 (Merck) 1,25 and glucose 10. The solution was gassed with 95% 02' 5%
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CO2 for 20 minutes before and throughout the experiment. The buffer was prepared
on the day of use and filtered through a 0,45 11mMillipore filter.
3.5.3 Organ Isolation
The rats were anaesthetised by an intraperitoneal injection with Intramed
Thiopentone sodium (sodium pentobarbital) 0,1mg/g. Once under anaesthesia, their
hearts were rapidly excised and placed in ice-cold Krebs-Henseleit solution to
minimize ischaemie injury while being transferred to the perfusion apparatus. During
this time blood and adipose tissue was collected from the animal. The blood was
centrifuged and immediately frozen, while the peri-renal adipose tissue was frozen in
liquid nitrogen.
The isolated heart was then mounted on the aortic cannula and perfused with an
oxygenated normothermic Krebs-Henseleit buffer in the Langendorff mode within 60
seconds of excision from the animal. All excess non-cardiac tissue was removed
from the heart. The left atrium was cannulated. The initial Langendorff perfusion
period lasted 10 minutes during which the heart was allowed to stabilize and blood
and other enzymes were washed out. A Sarns Model 5500 pump kept the buffer in
the resevoir at a constant level so as to maintain the perfusion pressure at 100cm
H20.
After this initial period the heart perfusion system was switched to the working heart
mode. The perfusate temperature was maintained at 37.0 DC by means of a water-
bath (Thermomix 1460, B. Braun Melsungen, Germany). A thermistor probe was
inserted into the right coronary sinus to monitor myocardial temperature before,
during and after ischaemia. The atrial perfusion pressure (preload) was maintained at
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a perfusion pressure of 20 cmH20 while the afterload was 100 cmH20. Heart rate,
coronary flow, aorta systolic and diastolic pressures and aortic output were measured
every 5 minutes during the experiment. The left ventricular pressure was monitored,
using a pressure transducer connected to a SP Amp, GSR Amp and stimulus isolator
(Powerlab, AD Instruments, Australia). After each experiment the hearts were freeze
clamped with Wollenberger metal tongs pre-cooled in liquid nitrogen and stored in a
-64°C freezer for biochemical analysis.
3.6 Experimental Protocol
3.6.1 Myocardial functional data collection
Myocardial functional data was collected after animals were on the diet for 12 weeks:
Pre-ischaemie perfusion (0-30 minutes): During the pre-ischaemie phase, hearts
were perfused in the Langendorff mode for 10 minutes for stabilization. They were
then switched to the working heart mode for 20 minutes. During the working heart
mode, functional data was documented at 5 minute intervals. (n=10)
Ischaemia (30-45 minutes): Hearts were subjected to 15 minutes total global
ischaemia and myocardial temperature was maintained at 36°C.
Reperfusion (45-75 minutes): The hearts were reperfused for 10 minutes in the
Langendorff mode before being switched over to the working heart mode for a further
20 minutes. Functional data was documented at 5 minute intervals.
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3.6.2 Myocardial tissue sample collection
Tissue samples were collected from a separate series of animals after 6 weeks, 9
weeks and 12 weeks for biochemical analysis.
Sample col/ection times
After 12 weeks on the diet:
a) Hearts were perfused under standard conditions, 10 minutes in Langendorff
mode and 20 minutes in working heart mode and then freeze clamped for
storage at -64°C. (n=7)
b) Hearts were again perfused under standard conditions, 10 minutes in
Langendorff mode and 20 minutes in working heart mode. These hearts were
also subjected to total global ischaemia (at 36°C). At the end of ischaemia the
hearts were freeze clamped and stored at -64°C.
After 6 weeks and 9 weeks on the diet:
Hearts were perfused under standard conditions, 10 minutes in Langendorff
mode and 20 minutes in working heart mode. The hearts were freeze-clamped
and stored at -64°C.
3.6.3 Perfusion Protocol
LO = Langendorff mode
WH = Workheart mode
t = Time points at which hearts were freeze-clamped
LO WH ISCHAEMIA LO WH
t 10' 20' t 15' t 10' 20' t
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3.7 Myocardial Function
In order to compare the pre-ischaemie and reperfusion function of the hearts in the
different groups, the heart rate (beats/min), coronary flow (ml/min), aortic output
(ml/min), aorta diastolic and systolic pressure and temperature (DC)were monitored
at 5 minute intervals before and after ischaemia.
Coronary flow (ml/min) and aortic output (ml/min) were measured manually by
collecting the coronary effluent and aortic output over a known time using a
measuring cylinder.
Aorta diastolic and systolic pressures (mmHg), and total work (mW) were recorded
on the Powerlab data collection system connected to a pressure transducer linked to
the aortic cannula of the working heart perfusion apparatus (AD Instruments, Castle
Hill, Australia).
3.8 Exclusion Criteria
Hearts with heart rates less than 180 beats/min or more than 330 beats/min, aortic
output of less than 30 ml/min and coronary flow of more than 25 ml/min were
excluded from the study at the beginning of the perfusion experiment. These values
were adapted for this study as the obese animals had poor heart functions and often
had high coronary flows due to their extreme heart size.
3.9 Biochemical analysis
3.9.1 Insulin determination
The assay for insulin determination is based on the procedure wherein 1251 labeled
insulin competes for a fixed time with insulin in the serum for sites on insulin-specific
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antibody. Since the antibody is immobilized to the wall of a polypropylene tube,
simply decanting the supernatant suffices to terminate the competition and to isolate
the antibody-bound fraction of the radiolabeled insulin. Counting the tube in a
gamma-counter then yields a value, which is converted by way of a calibration curve
to measure the insulin present in the sample in micro International Units/ml (f..lIU/ml)
(Paternostro et aI., 1999).
Assay procedure for insulin determinations
Four polypropylene tubes were labeled for total counts (T) and nonspecific binding
(NSB) in duplicate. Fourteen insulin Ab-Coated Tubes A were labeled (maximum
binding) and B through G in duplicate (polypropylene tubes coated with antibodies to
insulin). Additional antibody-coated tubes were labeled for samples, also in duplicate.
200f..l1of the zero calibrator A (Iyphilized processed human serum diluted in 6ml
distilled water) was pipetted into the NSB and A tubes, and 200f..l1of each remaining
calibrator and unknowns were added to each tube. Then 1ml of 1251 Insulin was
added to every tube and vortexed. The tubes were incubated for 18-24 hours at room
temperature, and following this step the tubes were decanted thoroughly. All tubes
were counted for 1 min in a gamma counter.
3.9.2 TNFg, determination
Serum preparation
Blood was collected from the animals and centrifuged at 1000g for 10 minutes at 40C
within 30 minutes. The supernatant was removed and stored in a freezer at -64 DC.
Prior to use, serum samples were thawed and equilibrated with room temperature.
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Myocardial tissue homogenization procedure for TNF Q:determination
Freeze-clamped hearts were homogenized in 5 volumes of cold lysis buffer
containing in mM/L: imidazole acetate 50, magnesium acetate 10, KH2P044, EDTA
2, in flM/L: N-acetylcysteine 50, Sulphur 12,5 (pH 7.6) (Meldrum et a/., 1998).
The homogenates were spun down in a microfuge at 4°C for 15 minutes to remove
particulate matter. The lysate protein content was determined using the Bradford
technique.
Adipose tissue homogenization procedure for TNFQ:determination
Peri-renal adipose tissue was removed and immediately frozen in liquid nitrogen for
storage and later processing. 200mg of frozen adipose tissue was homogenized in
400 fll of homogenization buffer containing 10 mmoIII TRIS-HCI, 250 mmoIII sucrose
and 5flg/5ml protease inhibitor (general). The homogenates were spun down in a
microfuge at 4°C for 15 minutes to remove particulate matter and the supernatant
was recovered for cytokine level determinations (Bastard et a/., 2000).
TNFQ:Assay Procedure
The levels of TNFa were determined using the OptEIA ™- ELISA kit (PharMingen
USA, Lot number M065951). The Cytokine sandwich ELISA is a sensitive enzyme
immunoassay that can specifically detect and quantitate the concentration of soluble
cytokine.
Microwells were coated with 100fll per well of Capture Antibody (Anti-rat TNFal
diluted in coating buffer (1:250) containing 0.1M Carbonate, pH 9.5. The plate was
incubated overnight at 4°C. During this period the coating antibody is adsorbed onto
55
Stellenbosch University http://scholar.sun.ac.za
the plastic microwells because of hydrophobic interactions. The following day the
wells were aspirated and washed 5 times with 300 Ill/well wash buffer (Phosphate-
buffered saline with 0.05% Tween-20) and after the last wash inverted and blotted on
absorbent paper to remove any residual buffer. This washing procedure was followed
throughout the experiment. After the plate washings, the immobilized antibodies
serve to specifically capture soluble cytokine proteins present in the samples.
The plates were then blocked with 2001ll/well Assay diluent (animal serum in buffered
solution with 0.15% ProClin-150 as preservative, PharMingen, USA) and incubated
for one hour at room temperature. During this period of incubation the standards and
samples were prepared. After the incubation period wells were washed again with
PBS-Tween 20 for 5 times. 100111 of each standard and sample were pipetted
carefully into the appropriate wells, the plate was sealed and finally incubated at
room temperature for two hours after which the wells were aspirated and washed 5
times.
After washing away unbound material, the captured cytokine was detected by biotin-
conjugated anti-cytokine antibodies (termed Detection antibodies), therefore in the
next step 100111 Detection Antibody (Biotinvlated anti-rat TNFa)_ diluted in Assay
diluent (1 :250) was added to each well, the plate was sealed and incubated for one
hour at room temperature. The plate was again washed 5 times with wash buffer.
100111 of Enzyme Reagent (Avidin-horseradish peroxidase conjugate) diluted in
Assay diluent (1 :250) was added to each well and the plate was sealed and
incubated for 30 min at room temperature. After this the plate was washed 7 times
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with wash buffer and each well was allowed to soak in the buffer for 30 seconds to 1
min.
100~1of TMB (equal volumes of Substrate Reagent A containing hydrogen peroxide
in a buffered solution and Substrate Reagent B containing 3,3',5,5'
tetramethylbenzidine in organic solvent, BO PharMingen USA) substrate solution,
which is a chromogenic substrate containing solution, was added to each well and
allowed to incubate in the dark, unsealed, for 30 min. Finally 50~1of Stop solution (2
N H2S04) was added to each well. The intensity of the coloured product generated by
the bound, enzyme-linked detection reagent was measured spectrophotometrically
using an ELISA-plate reader at a wavelength of 450 nm within 30 minutes of adding
the Stop solution. The cytokine concentrations of the samples were interpolated from
the standard curve obtained from the standards used in the assay. The levels of
TNFa in each sample are expressed in pg/gram ww for adipose and myocardial
tissue (Meldrum et ai., 1998).
3.9.3 cGMP determination
The myocardial cGMP levels were measured using the cGMP (1251)assay system
with Amerlex - M™ magnetic separation (Amersham International pic, Amersham
UK). The assay is based on the competitive binding between the unlabelled cGMP
and a fixed quantity of 1251-labelledcGMP for a limited number of binding sites on a
cGMP-specific antibody.
With known amounts of antibody and reactive ligand, the amount of radioactive
ligand bound by the antibody will be inversely proportional to the concentration of
added non-radioactive ligand. The cGMP that is bound to the antibody is then
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reacted with the Amerlex-M secondary antibody reagent, which contains secondary
antibody that is bound to magnetizable polymer particles. Separation of this bound
fraction is affected by either magnetic separation, or centrifugation of the suspension
and decantation of the supernatant. The amount of the cGMP in the bound fraction
can then be calculated once the radioactivity in the pellet is measured. The
concentration of the unlabelled cGMP in the sample is determined by interpolation of
the standard curve obtained (Du Toit et al., 1998).
Myocardial tissue homogenization procedure for cGMP determination
100 mg of frozen tissue was homogenized in cold 6% trichloroacetic acid at 4°C to
give a 10% w/v homogenate. This homogenate was then centrifuged at 2000g for 15
minutes at 4°C. The supernatant was recovered and washed three times with 5
volumes of water saturated diethyl ether. The upper ether layer was removed by
aspiration after each wash. The samples were then stored at 4°C overnight for the
remaining ether to evaporate.
cGMP Assay Procedure
On day 1 the standards and the Assay buffer containing 0.5M acetate buffer, pH5.8
with 0.01 % w/v sodium azide was used to reconstitute all other reagents involved in
the assay. Glass tubes (12x75mm) were labeled for the zero standard tube and the
unknowns, collectively termed acetylation tubes. Polypropylene tubes were also
labelled for total counts, zero standard, each standard dilution and unknowns.
The acetylation reagent was prepared by mixing 1 volume of acetic anhydride with 2
volumes of triethylamine in a glass vessel. 500).11of Assay buffer was pipetted into
the zero standard acetylation tube, and 500).11of each unknown or standard was
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added to the tubes. Following this step, 25111of acetylation reagent was added
carefully to all the acetylation tubes containing the standards and the unknowns. All
tubes were immediately vortexed after addition of the reagent. Acetylated samples
were diluted 1:6 with assay buffer.
In the following step, 100111from each diluted acetylated sample was pipetted into the
corresponding polystyrene assay tubes in duplicate. 100111of antiserum containing
rabbit anti-cGMP serum in 0.05M acetate buffer (1% w/v bovine serum albumin and
0.01% w/v sodium azide) was added to each assay tube except the tube for total
counts. This procedure was followed by vortexing all the tubes thoroughly. Finally all
the tubes were covered with foil and incubated at room temperature for one hour.
After this incubation period, 100111of [1251]cGMP (guanosine 3' ,5'-cyclic phosphoric
acid 2'-0-succinyl-3-[1251] iodotyrosine methyl ester in 0.05M acetate buffer) was
added to each assay tube, and all tubes were vortexed. The total count tubes were
stoppered. Finally, the tubes were covered and incubated overnight (18hours) at 4°C.
The following day, 500111of Amerlex-M secondary antibody reagent (donkey anti-
rabbit Amerlex-M) containing sodium azide, was added to each tube except the total
counts tube and vortexed thoroughly. These tubes were allowed to stand for 10
minutes at room temperature.
After this process all tubes were centrifuged for 10 minutes at 1500g, supernatant
liquids carefully discarded and finally the tubes were placed inverted on absorbent
tissues for 5 minutes to drain the remaining supernatants. The counts per minute of
each tube was counted over one minute in a gamma scintillation counter (Du Toit et
al., 1998).
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3.10 Statistical Methods
For the determination of statistical significance, the Unpaired Students t-test was
used. Data are presented as means +/- standard error of the mean (SEM). P< 0.05
was considered as significant. Microsoft Excel '97 and GPIS statistical programs
were used to perform all the tests.
The percentage aortic output recovery was measured as the post-ischaemie aortic
output divided by pre-ischaemie aortic output and multiplied by one hundred. These
values were obtained after 20 minutes reperfusion in the working heart mode.
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Chapter 4
RESULTS
4.1 Biometric Data
There was no significant difference in the weekly body weight gain when comparing
the HCO fed rats with the control rats. Weekly food consumption was significantly
higher in the HCO fed animals when compared with the control animals. The total
weight gain (over 12 weeks) of the HCO fed animals was significantly higher than that
of the controls (Table 4.1.1, Figure 4.1.2).
Table 4.1.1: Biometric data for control and HCD fed animals
Control HCD
Blood glucose levels were higher in the HCO fed animals when compared to the
controls (Table 4.1.2). The plasma cholesterol and HOL cholesterol levels were lower
in the HCO fed animals compared with the control group, while the plasma TAG was
significantly higher (Table 4.1.2). There was no difference in the non-fasted plasma
insulin levels of control animals compared with HCO fed animals. Because blood
glucose levels were higher in the HCO group compared with controls (Table 4.1.2),
the HCO fed animals may have developed mild insulin resistance.
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Table 4.1.2: Plasma lipid profiles and glucose and insulin levels after 12 weeks
on the feeding program for control and HCD animals
Control HCD
HDL = high density lipoprotein
TAG = triacylglyceride
chol = cholesterol
HCD = high caloric diet
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Figure 4.1.2: Weekly food consumption of control and HCD fed animals over 12
weeks.
The animals fed the high caloric diet consumed more food per week when compared
with their concurrent controls. The food given to the HCD group was however in a
wet form, while that of the control group was a dry pellet. The comparison of the
quantity of food consumed should therefore be interpreted with caution.
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4.2 Indices Used to Identify Cardiac Hypertrophy
When comparing the heart weight to body weight ratios of the control animals with
that of the HCD animals, there was a significant difference between the two groups,
suggesting the development of cardiac hypertrophy in the HCD animals. When
employing heart weight to tibia length as an index of cardiac hypertrophy (Yin et ai,
1982), there was no difference between the groups.
Table 4.2.1: Heart weight to body weight and heart weight to tibia length ratios
for control and HCD fed animals after 12 weeks on the diet
Control HCD
HW = heart weight
BW = body weight
TL = tibia length
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a) Pre-ischaemie function
4.3 Cardiac Mechanical Function Data
There was a significant difference between pre-ischaemie aorta systolic pressure
(ASP) and heart rate when comparing control hearts with the HCD hearts. There was
however no significant difference in the aorta diastolic pressures (Table 4.3.1, Figure
4.3.3, Figure 4.3.4 and Figure 4.3.5).
Table 4.3.1: Mechanical function for control and HCD hearts before ischaemia
(after 20 minutes WH perfusion)
Control HCD
CF = coronary flow
ADP = aorta diastolic pressure
ASP = aorta systolic pressure
HR = heart rate
Wt = total work
AO = aortic output
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b) Reperfusion Function
After ischaemia there was a reduction in aorta systolic pressure, total work and aortic
output in HCD hearts compared with control hearts. The aorta diastolic pressures in
the control group showed very little fluctuation during reperfusion. Although the heart
rates remained significantly higher, there was a decrease in aortic output of the HCD
hearts during reperfusion when compared with control hearts. The aortic output
recovery (%) was lower in the HCD hearts compared with the controls (Table 4.3.2,
Figure 4.3.4 and Figure 4.3.5).
Table 4.3.2: Mechanical function data for control and HCD hearts after
ischaemia (after 20 min WHperfusion)
Control HCD
recovery
CF = coronary flow
ADP = aorta diastolic pressure
ASP = aorta systolic pressure
HR = heart rate
Wt = total work
AO = aortic output
% AO = percentage AO recovery
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Figure 4.3.3: Aorta systolic and diastolic pressures for control and HCD before
ischaemia and during reperfusion.
ADP= aorta diastolic pressure
ASP = aorta systolic pressure
HCD = high caloric diet
Aorta systolic and diastolic pressure was recorded at 5 minute intervals before
ischaemia and during reperfusion. The aorta systolic pressure remained significantly
higher in the control hearts compared with the HCD group before ischaemia (100.75
± 2.49 mmHg and 89.89 ± 2.36 mmHg respectively after 20 minutes WH perfusion
(p<0.05)), and during reperfusion (93.93 ± 2.58 mmHg and 85.96 ± 1.59 mmHg
respectively after 20 minutes WH perfusion (p<0.05)). There was no significant
difference in aorta diastolic pressure of control hearts after ischaemia compared with
HCD hearts (68.29 ± 2.69 mmHg and 64.01 ± 1.50 mmHg respectively).
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Figure 4.3.4: Aortic output for control and HCD hearts before ischaemia and
during reperfusion.
AO = aortic output
HCD = high caloric diet
There was no significant difference between aortic outputs of the control hearts
compared with the HCD group before ischaemia (38.14 ± 1.73 ml/min and 33.67 ±
3.12 ml/min respectively after 20 minutes WH perfusion). During reperfusion the
aortic output of the HCD hearts decreased, reflecting a decline in cardiac function.
The aortic output in the HCD hearts continued to decrease with reperfusion, while the
aortic output in the control hearts stabilized (26.29 ± 2.24 ml/min and 16.67 ± 3.74
ml/min respectively after 20 minutes of WH perfusion (p<0.05)).
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Figure 4.3.5: % AO recovery for control and HCD hearts during 20 min WH
perfusion
AD = aortic output
HCD = high caloric diet
The aortic output recovery declined throughout reperfusion in the HCD hearts (47.86
± 7.87% after 20 minutes WH reperfusion), while the aortic output recoveries for the
control hearts remained more stable (66.67 ± 3.76% after 20 minutes WH reperfusion
(p<0.05)).
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4.4 Biochemical Parameters Measured
4.4.1 Serum TNFa levels
*60.......
E--I/)-'e
:J
e-
~-:.0
::c
Li:::' 10z
I-
50
40
30
20
o
Control HCD *p<O.05, n=5
Figure 4.4.1: Serum TNFa levels in control and HCD fed animals after 12 weeks
on the high caloric diet.
HCD = high caloric diet
Serum TNFa levels were lower in the control group (31.46 ± 0.32 AU) compared with
the HCD group (51.04 ± 5.14 AU). Depending on the relative concentrations of TNFa
in the serum, soluble TNFa receptors (sTNFRs) can either enhance or inhibit TNF's
biological activities. When TNFa and its soluble receptor are present in the serum,
they form complexes. The sTNFR can therefore bind with serum TNFa and interfere
with and compromise accurate ELISA measurements of total TNF protein levels. The
ELISA assay kit we used could not measure bound (to the soluble TNFa receptor)
TNFa levels in the serum. For this reason we chose to present serum TNFa data in
arbitrary units.
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4.4.2 Myocardial TNFa levels
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Figure 4.4.2: Myocardial TNFa levels in non-ischaemie and ischaemie control
and HCD fed animals.
HCD ;;;high caloric diet
Myocardial TNFa levels in the control hearts were not significantly different before
and during ischaemia (571.4 ± 132.9 pg/gram ww and 410.0 ± 12.5 pg/gram ww
respectively). TNFa levels before ischaemia were however considerably higher in the
control compared with the HCD hearts (571.4 ± 132.9 pg/gram ww and 312.0 ± 44.7
pg/gram ww respectively (p<0.05)). There was a significant increase in the
myocardial TNFa levels of the HCD fed animals when comparing the pre-ischaemie
with ischaemie TNFa levels (312.0 ± 44.7 pg/gram ww and 442.9 ± 12.4 pg/gram ww
(p<0.05)). TNFa levels were higher in the HCD hearts during ischaemia (442.9 ± 12.4
pg/gram ww) when compared with their concurrent ischaemie controls (410.0 ±12.5
pg/gram ww (p<0.05)).
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4.4.3 Adipose tissue TNFa levels
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Figure 4.4.3: Adipose tissue TNFa of control and HCD fed animals after 6, 9 and
12 weeks on the respective diets
HCD = high caloric diet
The TNFa levels in the adipose tissue of the control group and HCD were similar
after 6 and 9 weeks. After 12 weeks there was an increase in adipose tissue TNFa
levels of the HCD group (4.4 ± 0.4 pg/gram ww) compared with the concurrent
controls (2.5 ± 0.3 pg/gram ww (p<0.05)).
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4.4.4 Myocardial cGMP levels
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Figure 4.4.4: Myocardial cGMP levels of control and HCD fed animals after 6,9
and 12 weeks.
HCD = high caloric diet
There were no differences in the cGMP levels in the control hearts compared with the
HCD hearts after 6, 9 and 12 weeks on the respective diets.
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Chapter 5
DISCUSSION
We investigated and characterized the effects of obesity induced by a high caloric
diet and hyperphagia on myocardial hypertrophy, function and susceptibility to
ischaemic/reperfusion injury. We also tried to determine whether there is a correlation
between obesity, serum and myocardial TNF a levels, and cardiac hypertrophy.
Obesity is defined as the excessive storage of energy in the form of fat and plays a
pivotal role in the pathophysiology of metabolic and cardiovascular diseases (Caro,
1991; Sowers and Farow, 1996). Cardiovascular diseases directly associated with
obesity are cardiac hypertrophy and compromised ventricular function (Paulson and
Tahiliani, 1992). Obesity has recently been reclassified as a major, modifiable risk
factor for heart disease by the American Heart Association (Eckel and Krauss, 1998)
and is currently one of the most common metabolic disorders in developing countries.
Since the realization that obesity is a threat to the healthy individual, many models of
experimental obesity have been developed. Examples of these are genetically obese
animals and diet induced obese animals.
5.1 Development of a Model of Obesity and Cardiac Hypertrophy
In this study we wished to develop a model of diet induced obesity. This had to be
achieved without major changes to the macronutrient composition of the diet.
Pickavance and colleagues (1999) developed a model of hyperphagia-induced
obesity, which also induced cardiac hypertrophy. This diet contained a slightly
elevated carbohydrate content, which would be expected to have less severe effects
on lipid profiles than would a high fat diet. For example, a high fat diet in dogs was
accompanied by sympathetic overactivity, hyperglycemia, increased plasma insulin,
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and dyslipidemia, with elevated triglycerides and total cholesterol levels (Rocchini et
ai., 1989; Robles et ai., 1993; Villa et ai., 1998). High sucrose and fructose diets were
primarily accompanied by insulin resistance and hypertension (Storlien et ai., 1993;
Hulman and Falkner, 1994; Pagliosotti et ai., 1994; Daly et ai., 1997; Higashiura...m
ai., 1999). Interestingly a recent prospective study of 75 000 women in the USA
performed over 10 years has indicated that a high dietary glycemic load from refined
carbohydrates increased the risk of coronary heart disease, independent of other
known coronary disease risk factors (Liu et ai., 2000).
We found that subjecting the rats to a diet consisting of 65% carbohydrates for 12
weeks resulted in an additional 60% weight gain in the HCD (high caloric diet) fed
rats when compared with their concurrent controls (Table 4.1.1). As a result of
hyperphagia and the high calory content of their diet, the HCD rats became obese
and suffered from mild insulin resistance. These animals had increased blood
glucose levels, but their insulin levels were similar to those of the control rats (Table
4.1.2). These results support the findings of previous studies employing this model of
diet induced obesity (Wilding et ai., 1992; Pickavance et ai., 1999). In these latter
studies the blood glucose levels and insulin levels were obtained in fasted animals.
Due to the fact that the animals in our study were not fasted, comparisons with these
studies should be done with caution. In the current study the animals were however
subjected to the high caloric diet for 12 weeks compared with 8 weeks in the previous
studies (Wilding et ai., 1992; Pickavance et ai., 1999).
5.2 Lipid Profiles
When comparing the lipid profiles of the HCD animals with control animals changes
in the plasma cholesterol, HOL cholesterol and plasma TAG levels were observed
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(Table 4.1.2). The plasma cholesterol and HOL cholesterol levels were lower in the
HCO fed animals compared with the control rats, while plasma TAG levels were
higher. The increased plasma TAG levels corresponded with the findings of
Pickavance and colleagues (1999), using a similar model. To our knowledge most
studies to date measured lipid profiles of rats subjected to high fructose, sucrose and
fat diets (Matsui et ai., 1997; Morin et ai., 1997; Higashiura et ai., 1999). Subjecting
rats to a high fructose and lard diet for 2 weeks resulted in increased plasma TAGs,
but no differences were found in the plasma cholesterol levels. These findings were
proposed to be closely related to the insulin resistance in the rats (Matsui et ai.,
1997).
A short term (2 weeks) high caloric diet in humans caused increased plasma
triglyceride levels, and this increase may be linked to increase in hepatic fatty acid
availability resulting from lower splanchnic fatty acid oxidation (Mittendorfer and
Sidossis, 2001). In the Quebec cardiovascular study performed on 2103 men over a
period of 5 years, it was demonstrated that there is a highly significant negative
relationship between plasma HOL-cholesterol concentrations and TAG levels, i.e. low
HOL-cholesterol is associated with hypertriglyceridemia (Despres et ai., 2000).
Coronary artery disease and congestive heart failure are risk factors associated with
law HOL-cholesterol and high plasma TAG levels (Carroll et ai., 1996). Our rats may
have therefore been more susceptible to CAO suggested by the low HOL-cholesterol
and high TAG levels observed.
It has been suggested that dyslipidemia and insulin resistance coexist in obese rats,
and that the abnormal lipid profiles of the HCO fed rats may have been due to the
increased adiposity of the insulin resistant rats (Paulson and Tahiliani, 1992).
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Visceral adipose tissue has greater lipolytic activity than subcutaneous adipose
tissue, and the HCO fed rats had large visceral fat reserves. The subsequent release
of free fatty acids into the portal blood supply has been shown to contribute to
abnormal lipoprotein metabolism, including the presence of increased small, dense
LOL-cholesterol particles, lower HOL-cholesterol concentrations and insulin
resistance (Roust and Jensen, 1993; Kissebah and Krakower, 1994; Mauriege et al.,
1995; Hoffstedt et al., 1996; Lamarche et al., 1997; Hoffstedt et al., 1997). As a result
of technical difficulties associated with measuring LOL-cholesterol in rats, we did not
measure the levels of this lipid in our study.
5.3 Obesity, TNFa and Cardiac Hypertrophy
Our results show that cardiac hypertrophy was induced in the HCO fed animals, since
the heart weight to body weight ratios were increased compared with the control
group (Table 4.2.1). This is particularly significant as this ratio increased despite the
fact that there was a large increase in body weight of the HCO animals. Similarly, a
high fat diet induced obesity in rabbits caused cardiac hypertrophy (Carroll et al.,
1996). Pickavance and colleagues (1999) found, that subjecting rats to a high caloric
diet caused obesity, which is accompanied by cardiac hypertrophy. There are no
further studies to our knowledge, where a high caloric diet induced obesity in rats
resulted in cardiac hypertrophy.
Unfortunately, no significant differences were found when using heart weight to tibia
length ratios as an index of cardiac hypertrophy (Table 4.2.1). This method for
quantifying cardiac hypertrophy may only be reliable in fully-grown and old rats. Yin
and colleagues (1982) only found a good correlation between heart weight and tibia
length in rats that were 7 months and older. The rats in this study were between 2
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and 4 months old, which may account for the inconclusive results we obtained using
heart weight to tibia length as an index of cardiac hypertrophy. The reason we did not
subject the animals to the high caloric diet for a longer period of time was because
we hoped to avoid the development of hypertension and diabetes mellitus, which
would further complicate the interpretation of our data.
It is well known that the heart weight to body weight ratio is increased in obese
subjects. Autopsy findings on obese subjects revealed increased ventricular wall-
thickness and diffuse myocardial hypertrophy, which correlated well with body weight
(Amad et al., 1965; Alexander and Pettigrove, 1967). The increased heart weight was
mainly due to increased ventricular mass. The results from the Farmingham study
also confirmed the correlation between heart weight, ventricular thickness and body
weight (Gordon and Kannel, 1976). Obesity is therefore associated with left
ventricular hypertrophy, which has been demonstrated to be an independent
predictor of cardiovascular diseases (Lauer et al., 1991).
In addition to establishing whether a HCD is linked to the development of cardiac
hypertrophy, the aim of this study was also to determine whether there is a link
between TNFa secreted by adipose tissue and released into the circulating blood,
and the induction of cardiac hypertrophy. We also wanted to determine whether the
elevated serum TNFa levels lead to myocardial dysfunction in the normoxic heart.
Since obesity is accompanied by excessive body weight, increased metabolic
demands and increased blood volume, the chronic cardiovascular overload leads to
cardiac hypertrophy (Messerli, 1982). It is known that TNFa is over-expressed in
adipose tissue of obese rats and humans (Hotamisligil and Spiegelman, 1994). In a
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study done by Yudkin and colleagues (1999), it was shown that IL-6, TNFa and C-
reactive protein, arising in part from adipose tissue, might themselves be partly
responsible for the hemodynamic and metabolic abnormalities observed in obese
subjects. Yokoyama and colleagues (1997) concluded that physiologically obtainable
concentrations of TNFa provoked a hypertrophic growth response in the adult
mammalian cardiac myocytes. Kapadia and colleagues (1997) demonstrated that
hemodynamic pressure overloading in vivo under physiological conditions resulted in
de novo intramyocardial TNFa mRNA biosynthesis in the feline myocardium. These
studies suggest that TNFa may play an important role in the initiation and
development of myocardial hypertrophy.
Studies performed on other cytokines, such as CT-1 showed that CT-1 secreted from
cardiac nonmyocytes, was involved in the hypertrophic changes of cardiac myocytes
in coculture with the nonmyocytes. They proposed that CT-1 is an important regulator
in the process of cardiac hypertrophy (Kuwahara et aI., 1999; Latchman, 2000). It has
also been suggested that CT-1 has a cardioprotective role in the pathophysiology of
cardiac hypertrophy. There is therefore ample evidence supporting the role for
cytokines in both cardiac hypertrophy and protection (Sack et aI., 2000; Ghosh et aI.,
2000).
5.4 Obesity and Myocardial Function
Obesity is clearly linked to cardiovascular disease and congestive heart failure
(CHF). In a study done by Berkalp and colleagues (1995), this group found that
obesity caused ventricular relaxation and early filling abnormalities. Altered left
ventricular compliance has also been shown by Wilcken (1968), where patients
exhibited high end-diastolic ventricular and atrial pressures, which correlated with
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body weight and reduced left ventricular compliance. Left ventricular function, as
reflected by the ratio of stroke work index to left ventricular end-diastolic pressure
was also reduced in a more recent study (Divitiis et al., 1981). Data from the
Farmingham study also suggest that obese subjects are at a greater risk of
developing cardiomyopathy than their leaner counterparts (Gordon and Kannel,
1976).
Our results showed that before exposure to global ischaemia, hearts from the HCD
animals generated lower aorta systolic pressures compared with the control hearts
(Table 4.3.1, Figure 4.3.3). However, the heart rates were higher. This may explain
why the normoxic aortic output values for the HCD group were not significantly lower
than their concurrent controls (Figure 4.3.4). The exact cause of the increase in heart
rate of the normoxic hearts in the HCD animals is unknown. The aortic output, total
work, aorta diastolic pressures and coronary flow rates remained similar in the HCD
hearts compared with their concurrent control hearts, suggesting normal cardiac
function before ischaemia. This may be due to the young age of the animals used in
this study. Older animals that have been obese for longer may display more severe
functional abnormalities than seen in our study.
Garavaglia and colleagues (1988) found an increased cardiac output in obese
subjects. They suggested that this might be due to an increased stroke volume
caused by higher end-diastolic volumes accounted for by increased blood volumes in
obesity. Crandall and colleagues (1988) on the other hand showed that cardiac
output decreased proportionally with increased heart weight to body weight ratio.
They proposed that obesity in combination with other possible cardiac complications
resulted in greater cardiac dysfunction than either condition alone. It has also been
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observed that left ventricular hypertrophy associated with obesity caused an
abnormal ventricular filling pattern (Chakko et al., 1991). Similarly, Stoddard and
colleagues (1992) found a decreased peak diastolic filling rate in obese subjects with
a normal left ventricular mass. This would suggest that these changes in ventricular
filling in obese subjects may be independent of LV hypertrophy.
Our results showed an impaired systolic function and normal diastolic function (Table
4.3.1, Figure 4.3.3). This confirmed results obtained in studies on left ventricular
function in obese subjects. It has been demonstrated that an impaired systolic
function correlates with obesity and cardiac hypertrophy (Divitiis et al., 1981; Alpert et
al., 1985; Scaglione et al., 1992; Stoddard et al., 1992), yet some studies have
reported normal cardiac function (Nakajima et al., 1985; Carabello and Giltens,
1987). The presence or absence of left ventricular function abnormalities may be
strongly related to the degree and the duration of obesity.
5.5 Ischaemia and Reperfusion Injury
Reperfusion function was used as an indirect index of the severity of
ischaemia/reperfusion injury in our study. We wished to determine whether the
hypertrophied hearts from the obese animals were more prone to ischaemic injury
compared with their lean counterparts. For the purpose of this study the aortic output,
aorta systolic and diastolic pressures and total work were used as indices of cardiac
function.
Ischaemia alone can cause injury and reperfusion in turn may inflict microvascular
and myocyte damage thus compromising the return of normal coronary perfusion and
cardiac function (Maxwell and Lip, 1997). Ischaemia, if sustained long enough,
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causes changes in the cellular ultrastructure in the form of mitochondrial swelling,
membrane disruption, shortening of sarcomeres and an overall loss of contractile
function (Jennings and Ganote, 1976; Schaper et aI., 1979). These changes are
brought about by complex mechanisms involving depletion of energy stores (Neely et
aI., 1973; Jennings and Ganote, 1976; Jennings et aI., 1983), and accumulation of
metabolic waste products including lipid metabolites (Carr et aI., 1984).
During ischaemia, there is an increased intracellular Ca2+ accumulation (Clusin et aI.,
1983; Nayler et aI., 1988; apie, 1989) and generation of oxygen derived free radicals
(Hess and Manson, 1984; Kako, 1987). The generation of high levels of free radicals,
such as Ral and NO, triggered by the expression of proinflammatory mediators such
as cytokines, causes damage to the myocardium (Kilgore and Lucchesi, 1993),
Our results showed that after ischaemia, the aortic output, aorta systolic pressures
and total work decreased significantly in the HCD hearts compared with the control
hearts, suggesting that these hypertrophied hearts were more prone to
ischaemia/reperfusion injury than their concurrent controls (Table 4.3.2, Figures 4.3.4
and 4.3.5). Aorta diastolic pressures and coronary flows however showed no
differences. The decreased myocardial function may be due to an accelerated
calcium overload during reperfusion of the hypertrophied hearts. The mechanisms
involved in this acceleration are however not understood (Allard et aI., 1994). Another
contributing factor in ventricular dysfunction of hypertrophied hearts may be the
altered energy substrate use of these hearts, which may alter cardiac function.
Studies to date support the hypothesis that low glucose oxidation rates and high
glycolytic rates contribute to the exaggerated postischaemic dysfunction of
hypertrophied hearts (Wambolt et aI., 2000). There are to date no other studies
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evaluating the severity of ischaemie injury in models of diet induced cardiac
hypertrophy. Post-ischaemic left ventricular dysfunction was greater in hypertrophied
hearts than in nonhypertrophied hearts in various studies (Anderson et al., 1990;
Gaasch et al., 1990; Allard et al., 1994; Allard and Lopaschuk, 1996; Schone kess et
al., 1996; Wambolt et al., 1997). The post-ischaemic cardiac functions obtained in the
current study therefore support the findings of others using models of cardiac
hypertrophy.
The consequences of cardiac hypertrophy induced by other methods on cardiac
function are however extensively documented. Studies in sponateously hypertensive
obese rats have shown that the hypertrophied heart is extremely susceptible to
ischaemic injury (Shimamoto et al., 1982; Haneda et al., 1986). Tang and Taylor
(1995) found that isoproterenol-induced cardiac hypertrophy was associated with
significantly altered myocardial contractile force at various concentrations of calcium,
and an increased calcium influx via the sarcolemmal sodium-calcium exchanger may
be one of the contributors for the altered myocardial contractility.
5.6 Correlation between Serum and Myocardial TNFa Levels and
Ischaemia/Reperfusion Injury
TNFa is known to playa detrimental role in the pathophysiology of ischaemia and
heart failure. This cytokine is released in response to an environmental stress such
as pressure overload. Its expression occurs in almost all forms of cardiac injury
where its gene regulation is tightly controlled (Kapadia et al., 1995). TNFa is however
also known to be a growth factor and mediator of inflammation, and can induce self
amplification (Aggarwal and Natarajan, 1996). This cytokine is therefore proposed to
have dual effects. On the one hand it allows the host self-protection by inducing
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oxygen free radical scavenger enzymes and heat shock proteins, and on the other
hand causes an increase in oxygen derivatives such as NO (Ferrari et al., 1998).
There were elevated serum TNFa levels and elevated adipose tissue TNFa levels in
the HCD fed, obese rats compared with the control rats after 12 weeks (Figures 4.4.1
and 4.4.3). Studies have shown that increased TNFa levels are found in adipose
tissue of obese subjects (Hotamisligil et al., 1993). Elevated serum TNFa in obesity
has also been documented (Hube et al., 1997; Winkler et al., 1998; Hauner et al.,
1998). However it still remains unclear whether an increased adipose tissue TNFa is
reflected by elevated circulating TNFa levels.
On the other hand Hotamisligil and colleagues (1995) observed increased TNFa
expression in adipose tissue, but very low and almost undetectable circulating TNFa
levels in human obesity while other studies conducted on human subjects showed no
correlation between serum TNFa levels and adipose tissue (Hauner et al., 1998).
These data suggest a primary local role for the cytokine. It has been postulated that
increased TNFa secretion by the adipose tissue has a local function in regulating the
adipocyte size enlargement (Kern et al., 1995), but since TNFa has pleiotropic
effects (Mann, 1996), the increased serum cytokine levels may also be detrimental to
cardiac and other tissues. As proposed by Sack and colleagues (2000) (Figure
2.3.2.1 (2)), chronic elevated levels of TNFa are possibly maladaptive and
detrimental to the heart, and increased adipose tissue as seen in obesity may be a
source of circulating cytokines. The adipose tissue of the HCD fed animals produced
high levels of TNFa, which may have been released into the serum, as reflected by
the increased serum TNFa levels. These chronic elevated levels of the cytokine may
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account for the post-ischaemic myocardial dysfunction observed in the HCD fed
animals when compared with their concurrent controls.
To investigate whether myocardial TNFa levels changed in response to ischaemia,
we measured its levels before and during ischaemia. During normoxia, the levels of
myocardial TNFa remained significantly lower in the hypertrophied HCD hearts
compared with the control hearts (Figure 4.4.2). These results contradict other
studies done on mycardial TNF a levels in cardiac hypertrophy and obesity. Shioi
and colleagues (1997) demonstrated that increased proinflammatory cytokine
expression in the heart plays a role in the pathogenesis of cardiac hypertrophy.
During haemodynamic pressure overload due to isolated stretch, TNFa expression
and peptide production was also up-regulated in the adult myocytes (Kapadia ef al.,
1997).
The reason for reduced myocardial TNFa levels observed in the HCD hearts before
ischaemia may therefore be due to increased TNFa secretion from the myocardium
into the serum. TNFa released from the adipose tissue possibly induced its own
amplification and release from the myocardium, which is possibly also reflected by
the elevated serum TNFa levels. Whether endogenous TNFa directly induced
cardiac hypertrophy remains unclear, since the levels remain low in the myocardium
before ischaemia.
Interestingly, during ischaemia TNFa levels were elevated in the myocardium of the
HCD animals compared with the control animals (Figure 4.4.2). It has been
documented that ischaemia/reperfusion induces myocardial TNFa production (Lefer,
1970; Herskowitz et al., 1995; Gurevitch ef al., 1996). This elevated TNFa production
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in response to ischaemia may therefore be an important contributor to post-ischaemie
myocardial dysfunction (Yokoyama et aI., 1997). Post-ischaemic cardiac function of
the HCD animals was significantly decreased compared to corresponding controls,
which may be as a result of the increased myocardial TNFa production rate in these
animals. The fact that TNFa mRNA expression was not measured in our study
precludes us from being certain that TNFa synthesis was elevated in these hearts.
The HCD animals showed elevated levels of serum triglycerides. We however have
no data concerning tissue triglyceride levels in the hearts in our study. A previous
study (Hendrickson et aI., 1996) has shown that intramyocardial lipolysis of
triglycerides during ischaemia contributed to the increase of free fatty acids (FFA)
and their intermediates, which are associated with increased reperfusion injury.
Because TNFa is also known to stimulate lipolysis (Beutler and Cerami, 1988;
Grunfeld and Feingold, 1991; Spiegelman and Hotamisligil, 1993; Hotamisligil et al.,
1995), we believe that this mechanism may also have contributed to the exacerbation
of myocardial ischaemic and reperfusion injury.
5.7 Myocardial cGMP
Because cytokines are thought to stimulate myocardial iNOS activity, we also
measured cGMP levels in the hearts during the 12 week feeding program to
determine whether the NO-cGMP pathway was possibly activated in the HCD fed
animals.
Our results showed no differences in myocardial cGMP levels in the HCD fed animals
compared with control animals after 6, 9 and 12 weeks (Figure 4.4.4). Studies have
shown that TNFa induces iNOS, which causes an increase in NO production from
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cardiomyocytes and further impairs the ventricular function possibly by increasing
myocardial cGMP levels or altering specific sarcolemmal ion channels (Gross et al.,
1996; Kelly and Smith, 1997). TNFa induced desensitization of myofilaments to
calcium is also thought to be mediated by NO (Gurevitch et al., 1996; Goldhaber et
al., 1996). Several studies have demonstrated that myocardial infarction and allograft
rejection was associated with increased iNOS in the myocardium (Yang et al., 1994;
Worrall et al., 1995; Suzuki et al., 1996; Feng et al., 2001). Wang and Zweier (1996)
observed increased NO and peroxynitrite release from isolated rat heart after 30
minutes of global ischaemia. We did not measure cGMP levels during ischaemia in
our study and cannot comment on the activity of the NO-cGMP pathway during
ischaemia in our HCD and control hearts.
However, there are two mechanisms suggested in TNFa mediated contractile
dysfunction. The first mechanism occurs early, i.e. within minutes where TNF a
causes an increase in sphingosine, a stress induced second messenger, causing an
early phase myocardial function depression (Oral et al., 1997). The second
mechanism involves the induction of NOS and delayed myocardial dysfunction (Kelly
and Smith, 1997). The cGMP levels were not elevated in our HCD animals, and it
would therefore appear that the NO-dependent mechanism was not involved, which
is supported by the mechanical data obtained in the current study.
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Chapter 6
CONCLUSION
The animals subjected to a 12 week high calory feeding program became obese and
developed mild insulin resistance. These animals had abnormal lipid profiles, with
increased TAG but lower plasma cholesterol and HOL cholesterol levels compared
with their concurrent controls. High caloric diet induced obesity lead to cardiac
hypertrophy.
There was a strong correlation between elevated adipose tissue and serum TNFa
levels, and cardiac hypertrophy. Elevated serum TNFa levels did not lead to elevated
myocardial cGMP levels in normoxic hearts. The latter findings suggest that the
elevated serum TNFa levels had no effect on myocardial iNOS and NO-cGMP
pathway activity. It is therefore unlikely that the NO-cGMP pathway played a role in
the myocardial function of the HCO hearts. The obesity induced hypertrophic hearts
had poorer post-ischaemic myocardial functions when compared with their
concurrent controls. These findings suggest that the hearts from obese animals may
have been more prone to ischaemia/reperfusion injury than the non-hypertrophied
hearts.
Study Reservations and Proposed Future Work
Although we attempted to develop a model of obesity devoid of other cardiovascular
risk factors such as diabetes and hypercholesterolaemia, our animals had slightly
elevated plasma glucose and triacylglyceride levels. These secondary cardiovascular
risk factors may have contributed to the poorer reperfusion functions observed in the
HCO fed animals in this study. These additional risk factors also make the
interpretation of the data more complex. Another possible shortcoming in our model
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may have been the age of the rats. Older rats would be expected to develop more
severe cardiac abnormalities due to the prolonged obesity.
Based on our present data we cannot unequivocally state that adipose tissue was the
source of TNFa which lead to the elevated serum TNFa levels. Similarly our data do
not prove that the elevated serum TNFa levels are the direct cause of the cardiac
hypertrophy seen in our obese animals.
Future work should attempt to establish whether suppression of the elevation in
serum TNFa levels associated with obesity influences the degree of cardiac
hypertrophy in obese animals. We propose that animal models such as obese TNFa
knock-out mice be included in a future study investigating the effects of TNFa on
myocardial morphology and function. Alternatively, TNFa antibodies should be
administered to the obese rats to determine whether this alters the degree of cardiac
hypertrophy associated with obesity.
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